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BAYESIAN ANALYSIS OF LATENT TRAIT HIERARCHICAL MODELS FOR  
MULTIPLE BINARY OUTCOMES  
IN CLUSTER RANDOMIZED CLINICAL TRIALS 
 Xinhua Zhao, PhD 
University of Pittsburgh, 2010 
In clinical trials, multiple endpoints for treatment efficacy often are obtained, and in addition, 
data may be collected hierarchically. Statistical analyses become very challenging for this 
multidimensional hierarchical data, particularly with data collected at more than two levels. We 
propose a latent variable approach to assess an intervention effect on multiple binary outcomes 
from three-level hierarchical data.  This approach incorporates the correlation structure into one 
or more latent outcomes, and simultaneously regresses the latent outcome(s) on observed 
covariates. Random effects are included to model the hierarchical structure. Parameters 
estimation is done using a fully Bayesian approach implemented in WinBUGS.  
We first illustrate the approach in a cluster randomized clinical trial of three interventions 
to improve the processes of care for outpatients with pneumonia. Four binary outcomes are 
collected at the patient-level and clustered at the provider and clinic site levels. Simulation 
studies are conducted to check the algorithm and computational implementation. Then, we 
extend the one latent trait model to a two-latent trait model using eight outcomes from both 
outpatient and inpatient care. This latent modeling approach provides a comprehensive way to 
analyze multivariate hierarchical data. The method not only allows assessment of intervention 
effects with respect to multiple outcomes, but also assesses the relationship between outcomes, 
identifies those outcomes that carry the most information about the latent trait(s), and provides a 
summary measure of the “quality of care” at each clinical site. 
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 This work extends existing methods to model multivariate binary endpoints in a cluster-
randomized clinical trial. The public health significance of this study is the potential usefulness 
of this approach to quantify intervention (or exposure) effects with regard to multiple outcomes 
in hierarchical data setting, which arises frequently in medical and epidemiologic studies.  
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1.0  INTRODUCTION 
There are many situations in medical and other applied research settings where the outcomes of 
interest cannot be characterized by one single measurement on the individuals under study. For 
example, no single measure exists for outcomes such as blood pressure, quality of life, or 
physical functioning. To effectively capture all aspects of such outcomes, a number of 
measurements commonly are used. For example, blood pressure can be measured by systolic and 
diastolic blood pressures. Quality of life often is measured with a multi-item self-report 
questionnaire. Physical functioning is measured using an extensive self-report questionnaire 
and/or multiple performance-based tests. The result of such measurements is the representation 
of blood pressure, quality of life, or physical functioning by a set of scores for each individual.  
1.1 STATEMENT OF THE PROBLEM 
In clinical trials, multiple endpoints for treatment efficacy often are obtained (Pocock, Geller, 
and Tsiatis, 1987). For example, in stroke recovery no single outcome can serve as a gold 
standard indicative of treatment efficacy. The primary objective of analyses of this kind is not to 
identify the particular outcomes that differ between the groups, but rather to use all the data at 
hand to establish whether there is a difference between the groups.  Several statistical issues arise 
in evaluating a treatment effect from this type of data. One main issue is the multidimensionality. 
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Each of the several response variables measures a slightly different aspect of the response. 
because no single response variable suffices as a main outcome variable, methods that 
collectively consider all of the response variables are desired. The main question is how to use 
the multiple response variables to obtain a summary measure of the treatment effect that is 
readily interpretable. The problem is challenging because the multiple response variables may be 
defined on different numerical scales. If the data are collected hierarchically, the result is 
multidimensional hierarchical data. These methods also must account for the autocorrelation 
between individuals within the same cluster within each response variable, and the cross-
correlation between different response variables both across clusters and within the same cluster. 
Frequently, from a substantive perspective, there is a need to summarize all the multidimensional 
measures into a unidimensional composite score, such as an overall measure of quality of care in 
health care research.  
The frequently used approaches include individual outcome data analysis, dimension 
reduction of the data, and global test procedures. Each of those approaches fails to characterize 
the relationship between outcomes or summarize the variables. Latent variable models provide a 
natural way to analyze the complex multivariate data in this setting. A latent variable model is 
any model that includes the unobserved random variables. These models have been employed 
extensively in the areas of psychological and educational testing (Baker F.B. 1992) and the social 
sciences (Eye and Clogg, 1994). In recent years, the utility of latent variable models has been 
recognized and the use is increasing in medical research (for example see Catalano and Ryan, 
1992; Bollen and Long, 1993; Legler and Ryan, 1997; Sammel, Ryan, and Legler, 1997). 
However, latent variable models seldom have been used to test hypotheses about clinical 
outcomes in clinical trials and other designed studies (Donaldson 2003). 
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The overwhelming majority of the literature on latent variable models is frequentist in 
nature, using maximum likelihood estimation. MLE commonly treats latent variables as random 
and parameters as fixed. Inference usually is based on the marginal likelihood, the likelihood of 
the data given the latent variables, integrated over the latent variable distribution. The EM 
algorithm often is applied to maximize the likelihood. Unfortunately, in general no closed form 
for the multi-dimensional integrals exists, so that some approximations are required. Also, extra 
effort such as calculating the observed information matrix from the Louis formula is required to 
estimate standard errors (Louis, 1982). 
Bayesian estimation of latent variable models using Markov Chain Monte Carlo 
(MCMC) is an attractive alternative to maximum likelihood. Bayesians treat both latent variables 
and parameters as random variables. The difficulties induced by the complexities of the model 
and the multi-dimensional integrals can be handled efficiently using powerful computing tools 
such as the Gibbs sampler. An additional benefit is that samples are available from the joint 
posterior distribution of the latent variables. Often, these samples can be used to obtain important 
insights into structural relationships, which may not be apparent from the parameter estimates, 
such as checking the normality of the posteriors samples of latent variable to capture lack of 
model fit (Sik-Yum Lee 2007). Since about 2000, a number of authors have used MCMC 
methods to implement Bayesian analysis in various structural equation models (SEMs), 
involving nonlinear structure, heterogeneity and multilevel data (Lee and Song 2004, Lee and 
Song 2003, Dunson, et al. 2000).  The majority of the Bayesian approaches for complex SEMs 
were developed under the crucial assumption that the conditional distribution of the manifest 
(observed) variables, given the latent variables, is normal, while other distributions, such as the 
binomial (unordered binary data), have received limited consideration. 
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Very recently, latent variable modeling approaches have been used to profile health care 
providers on quality of health care. Quality of healthcare is an abstract and multidimensional 
construct that cannot be measured directly. There are three dimensions of quality of care: 
structure, process, and outcome. Structure measures are characteristics of the health provider. 
Process measures are the components of the encounter between a physician or other healthcare 
professional and a patient. Outcome measures refer to the patient’s subsequent health status 
(Blumenthal 1996). Normand et al. published a series of articles using latent variable models to 
quantify quality of health care using Gibbs sampling, involving a 2-parameter Normal-Ogive 
model (multivariate probit model) for multiple cross-sectional binary outcomes (2000, 2008), 
and multilevel multidimensional latent variable models under multivariate normal distribution 
with a threshold model for mixed binary and continuous outcomes in cross-sectional (2003) and 
longitudinal (2006) data settings. The aim of these studies was to estimate the unidimensional 
latent score in order to profile health care providers.  
Latent variable models have played little role in analyzing clinical trial data. For binary 
outcomes, item response theory (IRT) models with a probit-link were commonly used in 
literature. Given the easy interpretation and popularity of logit-link in clinical data settings, we 
will use logit link for the proposed method, which generalizes the conditional distribution of the 
manifest variable given the latent variable from the normal distribution to other exponential 
family distributions. In addition, existing standard software cannot analyze multiple outcomes 
from hierarchical data with more than two levels.  
In our work, we propose a general latent variable model to analyze an intervention effect 
with regard to multiple binary outcomes for a three-level model with multiple outcomes at the 
patient-level and clustering at the provider and site levels, using MCMC Bayesian estimation. 
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This latent modeling approach provides a comprehensive way to analyze multivariate 
hierarchical data.  Not only does the method allow assessment of intervention effects with 
respect to multiple outcomes, but it also quantifies the relationship between outcomes, identifies 
those outcomes carry the most information about the latent trait, and provides a summary 
measure of the “quality of care” of each clinical site. 
1.2 MOTIVATING EXAMPLE: THE EDCAP STUDY 
The Emergency Department Community Acquired Pneumonia (EDCAP) Trial (Yealy, Auble, 
Stone et al., 2004) motivated this proposed method. The EDCAP study was designed to compare 
the effectiveness and safety of three guideline implementation strategies of increasing intensity 
(low-intensity, moderate-intensity, and high-intensity) on quality of care of patients with 
community acquired pneumonia (CAP) in Emergency Departments (EDs). The low-intensity 
implementation arm reflected the quality improvement methods typically used by the 
collaborating state quality improvement (QI) organizations, which served as a usual care control. 
The moderate intensity arm also conducted an on-site educational session for ED medical 
providers and requested a QI plan for the admission decision. The high-intensity intervention 
added a multifaceted set of provider behavior change techniques (i.e. reminder forms, feedback, 
and bimonthly plan-do-study-act cycles) that continued through the year-long guideline 
implementation period. The intervention was randomized at the site (ED) level in the ratio of 3 
high intensity: 3 moderate intensity: 2 low intensity.  
The study guideline recommended outpatient care for low risk patients with CAP who 
presented for the ED and inpatient care for high risk patients. The study practice guideline 
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recommended four processes of care for outpatients (i.e.,  oxygen assessment, first dose of 
antibiotics in ED, treatment with compliant antibiotics in the ED, and compliant antibiotic 
therapy upon discharge ) and four processes of care for inpatients (oxygen assessment, blood 
cultures before antibiotic administration, antibiotic administration within 4 hours and treatment 
with compliant antibiotic therapy in ED). Those eight binary outcomes were used to illustrate the 
proposed method, with “1” indicating that the patient received the recommended process of care, 
“0” otherwise.  
The EDCAP study has a 3-level hierarchical data structure, in which multiple outcomes 
are nested within patients, patients are nested within providers, and providers are nested within 
clinical sites (EDs). Of the 3201 patients were seen by 407 providers at 32 clinical sites, 1125 
received outpatient care and 2076 received inpatient care.  Intervention was randomized at site 
level.  
The primary study results were published by analyzing each outcome separately (Yealy, 
Auble, Stone et al., 2005). Many pairwise comparisons were conducted and subjective 
conclusions of the overall effect were based on the multiple tests.  The information derived from 
these individual outcome analyses can be overwhelming, and the increased Type I error is an 
issue. Further, in this multidimensional outcome data, we expect some relationships between the 
outcomes, so that modeling outcomes independently could result in a loss of efficiency.  
 The purpose of our work is to develop a statistical model to assess an overall intervention 
effect. Specifically, we propose a general latent variable model to analyze the intervention effect 
with regard to multiple binary outcomes with a 3-level hierarchical data structure, using a fully 
Bayesian approach. This proposed model framework incorporates the correlation structure into 
one or more latent outcomes, and simultaneously regresses the latent outcome(s) on 
 7 
interventions.  This analysis will address the question of whether there is significant variability in 
the quality of care across sites, and whether the intervention explains some of this variability. 
This latent modeling approach provides a comprehensive way to analyze intervention effect in 
multivariate and hierarchical data.   
In Chapter 2, we review relevant literature. In Chapter 3, we describe a Bayesian 
formulation of the proposed one-latent trait and two-latent trait models. The EDCAP data is 
analyzed sequentially in terms of complexity. First, each outcome was analyzed individually   
using both a Bayesian approach and maximum likelihood with random effects to account for 
clustering effects at the site and provider levels, and results were presented in Appendix A. 
Second, in Chapter 4, a one-latent trait model is proposed to assess an overall intervention effect 
using outpatient data. Then, in Chapter 5, the one latent trait is extended to two-latent trait model 
to assess the intervention effect on both outpatient care (4 outcomes) and inpatient care (4 
outcomes). We conclude in Chapter 6 by discussing some limitations and extensions. Selected 
output and figures of Bayesian implementation are listed in Appendix B.  
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2.0  REVIEW OF THE LITERATURE 
Multiple outcomes are common in the social and behavior sciences, and increasingly, so in 
biomedical studies. Statistical analysis is challenged by such data in studying the relationships 
between outcome measures and associated covariates. The development of statistical methods for 
the analysis of multiple outcomes has been an area of active research for decades.  
2.1 NON LATENT VARIABLE APPROACHES 
Traditionally, one frequently used approach is to analyze the treatment effect on each response 
variable separately, presenting multiple P-values and drawing overall subjective conclusions. 
While this approach is simple and easy to implement, it has limitations. Evaluating individual 
response variables is informative but often fails to provide an overall statement of the treatment 
effect. It is commonplace to interpret a trial as positive if any endpoint has a treatment difference 
significant at the 5% level, which increased the risk of overall Type I error rate (inflation of false 
positives). Also, it fails to advantageously borrow strength across the response variables, i.e., it 
fails to combine the related information about the treatment effect from the various response 
variables. Hence, for multiple endpo ints without prespecified priorities, it is challenging to 
preserve a small overall Type I error rate and allow for correlated endpoints. One could simply 
apply a Bonferroni correction; however, this approach can be very conservative, particularly for 
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correlated endpoints. For related outcomes likely to be affected in a similar manner, a 
multivariate approach that allows for an overall assessment of intervention effects by combining 
information from these related outcomes is preferred, which could detect the intervention effects 
with better statistical power (Gray SM and Brookmeyer R 1998,  Sammel M, Lin H and Ryan L 
1999) 
Another commonly used approach is to reduce the dimensionality of the data. Very 
simple approaches include calculating a summation score for several continuous variables or 
collapsing multiple binary outcomes into a single binary outcome that indicates the presence of 
at least one of the endpoints of interest. This could also been accomplished in a more complex 
way using variable reduction techniques, such as factor analysis or principal components 
(Morrison, 1976). This analysis apporach is named as two-stage factor analysis, a two-step 
procedure, wherein one first performs a factor analysis or principal components analysis to 
identify a linear combination of outcomes that are most correlated with each other, then treats 
this linear combination as fixed and known without measurement error and models this linear 
combination as a function of covariates (Sammel, 1999).  This approach may not lead to 
interpretable results and the data reduction may result in biased estimates, a loss of information 
(Gray SM and Brookmeyer R 1998, Croon Bolck, 1997), and most important, uncertainty in the 
aggregated scores is difficult to quantify (Gray and Brookmeyer, 1998). 
Another approach is the use of global testing procedures based on suitable multivariate 
models to compare outcomes between different groups. Testing procedures for multiple 
outcomes have been described by O’Brien (1984), Pocock (1987) and Legler (1995) among 
others. O’Brien (1984) based his methods on generalized least squares (GLS) as well as a 
nonparametric rank-based approach. Pocock et al. (1987) extended O’Brien’s GLS approach to 
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included binary and survival endpoints. Legler et al. (1995) used generalized estimating equation 
(GEE)-based score tests for a general M-group comparison. Although a global test can assess 
whether or not groups differ with respect to multiple outcomes, they fall short in exploring the 
relationship between outcomes. There is no well-recognized best way to accomplish this. One 
simple approach is to use some kind of multiple comparisons technique to identify which 
individual outcomes are affected. Ironically, attempting to do so may sometimes undermine the 
rationale for using a global test in the first place.  Global analyses have been criticized often on 
the grounds that combining multiple outcomes may obscure a real effect if only one or two 
outcomes are actually affected by the intervention. In general, global tests will be more powerful 
and are recommended in practice when all the outcomes are closely related and be similarly 
affected by the variable of interest. 
None of these approaches described above provide a comprehensive way to study the 
relationships between outcomes, to synthesize (or summarize) these variables, or to quantify the 
multivariate outcome as a univariate composite score and simultaneously assess the relationship 
between this composite score and the observed covariates with measurement errors considered in 
one model framework. However, latent variable models provide a natural and comprehensive 
way to analyze data with multiple outcomes and hierarchical data structure. 
2.2 LATENT VARIABLE MODELS 
Latent variable models refer to any models that include unobserved random variables. Such 
models assume the existence of one or more latent variables, i.e., quantities that are not directly 
observed but thought to be underlying the measured responses.  Latent variable models have 
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been used extensively in the areas educational testing, psychology, and social science for 
studying interrelationships among observed and latent variables, because they provide a natural 
way to analyze data with multiple dimensions. The utility of these models in medical research 
has only quite recently been recognized (Bentler PM and Stein JA 1992, Rabe-Hesketh S. and 
Skrondal A. 2008). One advantage of the latent variable model is that a one degree-of-freedom 
test can be used to test for the overall exposure effect, and could be more powerful compared to 
the a M degree-of-freedom test (Sammel 1999). Another advantage of the latent variable model 
is that it naturally yields a summary measure for each individual that can be interpreted as 
individual severity score.   
The classification scheme of traditional latent variable models was summarized by 
Skrondal A. and Rabe-Hesketh S (2007), based on metrics for the observed and latent variables.  
For both continuous latent variable(s) and observed variables, the models include common factor 
models, structural equation models, linear mixed models and covariate measurement error 
models; latent trait models/IRT for continuous latent variable(s) and categorical observed 
variables; latent profile models for categorical latent variable(s) and continuous observed 
variables; and latent class models for both categorical latent variable(s) and observed variables 
 The factor analysis model is the most basic statistical model for studying the 
relationships among latent and observed variables. To deal with complex data sets in various 
fields, the factor analysis model has been generalized to more sophisticated models (Bentler and 
Weeks 1980). These multivariate models are commonly called structural equation models 
(SEMs). A SEM with latent variables provides a very general framework for modeling the 
relationships in multivariate data (Bollen 1989). In the following, in order to have a better 
understanding of the proposed latent variable models, we will review various latent variable 
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models, including factor models, item response models, SEMs, and the recent work on unifying 
and extending the classical latent variable models within a general framework. We also review 
Bayesian estimation for latent variable models. 
2.2.1 Common factor models 
For i = 1, . . . ,N  independent subjects with j=1,…, I continuous items, a unidimensional 
common factor model can be written as  
,ij j j i ijy β λ η ε= + +  where ~ (0, ), ~ (0, )i ij jjN Nη ψ ε θ , ( , ) 0i ijCov η ε =                        (2.1)               
In (2.1), jβ  represents the measure-specific mean, iη  
jλ
is the common factor or latent trait 
for subject i, is a factor loading for the jth ijε item, are unique factors or measurement error 
(which are not separately identified when there are no replicates) and θ jj
   Without any parameter constraints, the above unidimensional common factor model is 
not identified (several sets of parameter values can produce the same probability distribution) 
because multiplying the standard deviation √ ψ of the common factor by an arbitrary positive 
 is the measurement 
error variance. The model framework could be considered as a multivariate model that 
incorporates the correlation structure into a single latent outcome, which is a weighted 
combination of the observables. The common factor can represent any hypothetical construct, 
i.e., a concept that cannot even in principle be directly observed, intelligence and depression 
being prominent examples. In this case the measures j are typically questions or items of a 
questionnaire or structured interview. The answer to a particular item is therefore a reflection of 
both the hypothetical construct and an item-specific aspect, referred to as the common and 
specific factors, respectively. 
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constant can be counteracted by dividing all factor loadings jλ  by the same constant. 
Identification is achieved either by ‘anchoring’, where the first factor loading is fixed to one (λ1
Hypothetical constructs are often multidimensional. The above one-dimensional factor 
model could be generalized to a less restrictive multi-dimensional (“M-dimensional”) factor 
model. An M-dimensional factor model can be formulated as 
 
= 1), or by ‘factor standardization’, where the factor variance is set to a positive constant (ψ = 1). 
The models resulting from either identification restriction are equivalent.  
1 1 ...ij j j i jM iM ijy β λ η λ η ε= + + + +           
In matrix form i i iy β η ε= + Λ +  
where β  is a vector of item-specific constants, Λ  is now an n × m matrix of factor loadings with 
element pertaining to item j and latent variable l denoted λjl iη ,  is a vector of M common factors 
with covariance matrix Ψ  , and jε  is a vector of unique factors with diagonal covariance matrix 
Θ .We define Ψ ≡ Cov(ηi) and assume that E(ηj iε) = 0, E( ) = 0, and Cov(ηi, iε ) = 0.  
In the multidimensional case, an important example of a restricted model is the 
independent clusters model where Λ  has many elements set to zero such that each indicator 
measures one and only one factor. Such a configuration makes sense if one set of indicators is 
designed to measure one factor and another set of indicators to measure another factor. For 
example, matrix (2.3) in below depicts an independent clusters two-factor model where each 
factor is measured by three separate items. The model identification is achieved by anchoring, 
where we have the scale of each factor by setting one factor loading to 1.  
(2.2) 
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1
3
4
5
1 1
22 221
3 1 331
4 2 4
525 5
626 66
01
0
0
10
0
0
i i
i i
i i i
i i i
i i
i i
y
y
y
y
y
y
β ε
β ελ
β η ελ
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2.2.2 IRT models 
When the response items are dichotomous or ordinal, the above factor model can be extended to an 
IRT model using a generalized linear model formulation. The conditional probability of a particular 
response given the latent trait (or factor) typically is specified by a logit or probit link function. The 
IRT model has been developed in the context of educational testing.  Let ijy  denotes the observed 
binary outcome of item j (correct or incorrect) on subject i, and iη  
exp( )
Pr( 1| )
1 exp( )
j i j
ij i
j i j
y
λ η β
η
λ η β
−
= =
+ −
represents the continuous 
unobserved ability of the examinee. A two-parameter logistic (2-PL) model can be formulated as 
 
There are two parameters associated with each item, an intercept and a factor loading. jβ  
represents the item difficulty, iη  jλrepresents ability,  
jλ
is referred to as the discrimination 
parameter because items with a larger  
j iλ η
better discriminates between subjects with different 
abilities.  In this 2-PL model, an item can be easier than another item for low abilities but more 
difficult than the other item for higher abilities, due to the item-examinee interaction . The 
two-parameter (2-PL) IRT model could be reduced to a one-parameter (1-PL) IRT model by 
(2.4) 
(2.3) 
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constraining factor loadings jλ  to all be 1, which is just a random intercept logistic model 
without covariates. The Rasch model could be obtained by taking iη as fixed in the 1-PL model.    
 
The two-parameter IRT model with probit link is called the Normal-ogive model (Lord FM 
1952)  
1[Pr( 1| )]ij j i i jy η β λη
−Φ = = +  
Here Φ (·) is the cumulative standard normal distribution and 1−Φ  (·) is the probit link.  
2.2.3 Structural equation models (SEM)  
SEMs, also called simultaneous equation models, are multivariate regression models with latent 
variables. SEMs provide a broad framework for modeling means and covariance relationships in 
multivariate data. In general, SEM combines the ideas of factor analysis and regression. Unlike 
the more traditional multivariate linear model, however, the response variable in one regression 
equation in a SEM may appear as a predictor in another equation. Factor models and IRT models 
are important in their own right for modeling the relationship among the observed and latent 
variables, but also as building blocks in SEMs, where relationships among latent variables are 
modeled. SEM also is referred to as covariance structure analysis. In this structural model, there 
could be both latent dependent variables and latent explanatory variables. 
The standard SEM, in particular the LISREL (linear structural relationship) model 
(Jöreskog KG 1977), is composed of two components. The first component is a confirmatory 
factor analysis model, which relates the latent variables to their entire corresponding manifest 
(observed) variables (indicators) and takes the measurement error into account. This component 
can be regarded as a regression model that regresses the manifest variables on a small number of 
(2.5) 
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latent variables.  The second component is again a regression type structural equationthat regresses 
the endogenous (dependent) latent variables with the linear terms of some endogenous and 
exogenous (independent) latent variables. There are several ways of parameterizing SEMs with latent 
variables. Here we will use a parameterization suggested by Muthén (Muthén BO 1984) due to its 
convenience in application.  
The measurement part of the model is the confirmatory factor model specified in equation 
(2.1) 
1 1 ...ij j j i jM iM ijy β λ η λ η ε= + + + +  
 The structural part of the model specifies regressions for the latent variables on other latent 
and observed variables 
 
i i i iη α η χ ζ= +Β +Γ +
      
Here iη  is a vector of latent variables with corresponding lower-triangular parameter matrix 
B governing the relationships among them, α is a vector of intercepts, Γ  a regression parameter 
matrix for the regression of the latent variables on the vector of observed covariates iχ , and iζ  is a 
vector of disturbances. We define Ψ ≡ Cov(ζi) and assume that E(ζi)=0, Cov( iχ ,ζi) = 0 and 
Cov(
iε , ζ i) = 0, 
 An important special case is the Multiple-Indicator-Multiple-Cause (MIMIC) model 
(Joreskog KG 1975), which imposes the restriction B = I in the structural model, so the structural 
model reduces to 
i i ixη α ζ= +Γ +  
The MIMIC model is a one-factor model, where the factor is measured by multiple 
indicators and regressed on several observed covariates or “causes”.  
(2.6) 
(2.7) 
(2.8) 
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2.2.4  Generalized Linear Latent and Mixed Models 
Recognizing the mathematical similarity of a wide range of latent variable models, Rabe-
Hesketh and Skrondal proposed a very general framework to unify and generalize various the 
classical latent variable models, including the multilevel, factor, item response, latent class, 
structural equation and longitudinal models. The model framework is named as Generalized 
Linear Latent and Mixed Models, or GLLAMMs (Rabe-Hesketh et al., 2007; Skrondal & Rabe-
Hesketh, 2004). The GLLAMM model can be written down explicitly in its full generality just 
like the unifying LISREL model. 
GLAMM combines features of generalized linear mixed models (GLMMs) and SEMs. 
GLLAMMs consist of two building blocks: a response model and a structural model. The 
response model specifies the distribution of the observed responses conditional on the latent 
variables and covariates (via a linear predictor and link function) and in the structural model the 
latent variables themselves maybe regressed on other latent and observed covariates. 
The response model generalizes GLMMs to incorporate factor structure in addition to 
random intercepts and coefficients. Conditional on the latent variables, the response model of 
many latent variable models is a generalized linear model. As for such models, the response 
model of GLLAMMs has three components: a link, a distribution and a linear predictor. The 
conditional expectation of the response y, given x, z and η, is ‘linked’ to the linear predictor via a 
link function g(·). 
1
( [ | , , ]) ` `
M
ij ij mi mij m
m
g E y x z X zη β η λ
=
= +∑  
Common combinations of links and distributions include: (i) the identity link and normal 
distribution for continuous responses; (ii) the logit, probit or complementary log–log link and 
(2.9) 
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Bernoulli distribution for dichotomous responses; (iii) the cumulative version of these links and 
multinomial distribution for ordinal responses; and (iv) the log link and Poisson distribution for 
counts. The right side of the equation is the linear predictor, η  is the vector of all latent variables 
in the model, x and z denote vectors of covariates. The elements of xij are covariates with ‘fixed’ 
effects β. The mth latent variable  is multiplied by a linear combination m`ij mz λ  of covariates 
 where  are parameters (usually factor loadings). Some traditional latent variable models 
could be viewed as special cases, such as the common factor model and IRT models.   
 The structural model is similar to the structural part of SEM specified in (2.7) except that 
it is a multilevel structural model where latent variables and observed variables can vary at 
different hierarchical levels. This includes the conventional single-level structural model as a 
special case. 
2.2.5 Bayesian estimation of latent variable models 
Most of the literature on latent variable models is frequentist in nature, based on maximum 
likelihood estimation (MLE) (for examples see Bock and Aitkin, 1981, Rabe-Hesketh et al., 
2004 and 2005, Schoenberg and Richtand, 1984). Latent variables are treated as random and 
parameters are fixed, inference is usually based on the marginal likelihood, the likelihood of the 
data given the latent variables, integrated (or summed in the discrete case) over the latent 
variables distribution. In the cases of multivariate normal latent variables and multivariate 
normal responses, the marginal distribution of the response given the latent variables is 
multivariate normal (multivariate normal marginal distribution), the MLE is relatively 
straightforward because the integral involved in the marginal likelihood can be explicitly solved 
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and expressed in closed form. However, in non-normal models, such as item-response models, 
there generally is no analytic expression for the likelihood, i.e., the likelihood does not have a 
closed form, and approximations are needed (Skrondal A and Rabe-hesketh S, 2004). There are 
several more or less accurate approximate methods of integration, including numerical 
integration using quadrature or adaptive quadrature (as implemented in SAS NLMIXED and the 
Stata program gllamm), or Monte Carlo integration (simulated likelihood). Different methods for 
maximizing the likelihoods include the Expectation-Maximization (EM) and Gradient methods 
of Newton-Raphson and Fisher Scoring algorithms.  
 In contrast, Bayesian estimation treats both latent variables and parameters as random 
variables, so that there is no distinction between the two types of variables. When the likelihood 
does not have a closed form, the Bayesian alternatives using MCMC for latent variable models 
are attractive (Sik-Yum Lee 2007a, Sik-Yum Lee 2007b). MCMC methods allow estimation of a 
very wide range of models and have become increasing popular. The difficulties induced by the 
complexities of the model and the multi-dimensional integrals can be handled efficiently by 
means of powerful computing tools in statistics, such as the Gibbs sampler (Geman and Geman, 
1984). An additional benefit is that samples are available from the joint posterior distribution of 
the latent variables.  
A major breakthrough for Bayesian estimation of latent variable models is the idea of 
data augmentation that was proposed by Tanner and Wong (1987). The strategy is to treat latent 
quantities (Ω ) as hypothetical missing data and augment the observed data with them so that the 
posterior distribution based on the “complete” data is relatively easy to analyze. More 
specifically, instead of working with the intractable posterior density ( | )P yθ , we will work 
with ( , | )P yθ Ω , where Ω  is the set of latent variables in the model. For most cases, ( , | )P yθ Ω  
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still is not in closed form and it is difficult to deal with it directly. However, on the basis of the 
complete-data set ( , )yΩ , the conditional distribution [ | , ]yθ Ω  is usually standard; moreover, the 
conditional distribution [ | , ]yθΩ can be derived from the definition of the model without much 
difficulty. Consequently, we can apply some MCMC methods to simulate the observations from 
( , | )P yθ Ω by drawing observations iteratively from their full conditional densities ( | , )p yθ Ω  
and ( | , )p yθΩ ( Sik-Yum Lee 2007a). Most of the full conditional distributions are the standard 
normal, gamma or Wishart distributions. Simulating observations from them is rather 
straightforward. For nonstandard conditional distributions, the Metropolis-Hastings (MH) 
algorithm (Metropolis el al., 1953; Hastings, 1970) may have to be used for efficient simulation. 
The freely available software WINBUGS (Windows version of Bayesian inference Using 
Gibbs Sampling, Gilks WR 1994) is a useful and powerful tool for Bayesian analysis. It allows 
users to evaluate complex models without implementing the technical details of MCMC for each 
new problem. The software will set up the MCMC process and conduct the sampling, so that the 
users are able to focus on model design and validation. It could produce reliable Bayesian 
statistics for a wide range of statistical models, including SEM models (Sik-Yum Lee 2007a,). 
The algorithm used in WinBUGS is mainly developed using MCMC techniques, such as the 
Gibbs sampler and the MH algorithm. This software is able to produce reliable Bayesian 
statistics, including the Bayesian estimates with their standard error estimates, and the Deviance 
Information Criterion for model comparison and goodness-of-fit assessment of the hypothesized 
model. 
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3.0  PROPOSED METHOD 
We describe our method in the context of EDCAP example. The EDCAP study has a 4-level 
hierarchical data structure, in which multiple measurements are nested in patients, patients are 
nested in providers and providers are nested in clinical sites.  The intervention is randomized at 
the site level. One question of interest is whether the intervention is association with site level 
variation. Assuming that each site has one underlying trait (e.g., quality of pneumonia care), we 
construct a latent trait at site-level and then model the association between this latent trait and the 
intervention.  
To set the notation, let i denote the level-4 units (sites), j denote the level-3 units 
(providers), k denote the level-2 units (patients), and h denote the level-1 units (measurements or 
items). Let Yijkh be the dichotomous value of the hth response of the kth patient treated by 
provider j in the ith (i=1,2,…., 32 ) site (ED ). The two covariates that will be modeled are one 
level-2 unit (patient-level) covariate, risk status (Zijk 0=low risk, 1=high risk)), and one level-4 
unit (site-level) covariate, intervention level (Xi(x i1, xi2
 
) (0,0)=low, (1,0)=moderate, (1,1)=high 
intensity intervention). 
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3.1 ONE-LATENT TRAIT MODEL 
EDCAP outpatient data with four outcomes were used to illustrate the proposed method 
3.1.1 Model specification 
Though data are collected at patient level, this analysis focuses on site-level variation. We 
formalize the likelihood function by writing the within-site and the between-site models 
separately, with the within-site model linking the outcomes to  patient risk status and various 
random effects, and between-site model linking the site-level random effect  to the latent 
variable, with the latent mean modeled as a function of the intervention.  
Within-Site Model. The outcome variable is assumed to follow a binomial distribution 
and is linked by logit link to the patient-level covariates, a patient-level random effect, a 
provider-level random effect, and a site-level measurement-specific random effect, 
0h 1h 0h 1h ijk ijk ij( | , , , , , ) + z + + +ijkh ijk ij ih ijk ihLogit y zβ β µ υ η β β µ υ η=        (3.1) 
where,  
Yijkh
β
, binary effectiveness outcome measure 
0h , a baseline for each measure, indicating performance of  the h th process of care at an 
average site with the low-intensity intervention for low risk patients. The lower the value, the 
lower the average probability of receiving the h th
β
 process of care. 
1h,
Z
 a fixed measure-specific regression coefficient for the patient-level covariate 
ijk, as defined above, patient risk status (i.e., 0= high risk, 1= low risk) 
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The parameter µijk is patient level random error term such that the responses are 
conditionally independent at the patient level. It is assumed to be normally distributed with zero 
mean and constant variance (i.e., µijk ~ N (0, σ2
The parameter ν
)) 
ij is a provider level random error term that allows for correlation among 
patients within a provider. It is assumed to be normally distributed with zero mean and constant 
variance (i.e., νij ~ N (0, τ2
The parameter η
). 
ih, a measurement-specific site level random effect for measure h in site 
i, permits heterogeneity across the sites and allows for correlation among patients within a site.  
It is assumed to be normally distributed with a non-zero mean as a function of intervention effect 
and a measurement-specific variance (i.e., ηih ~ N ((λhθi, ψh2)), which are specified in detail 
below. It is further assumed that the random effects µijk , νij   and ηih 
Between-Site Model. To model the correlation between the multivariate outcomes at the 
site-level, we relate the site-level random effects to one latent variable θ
are mutually independent. 
i
                               
, such that the four site-
level effects are conditionally independent given the latent variables. 
2
2
,  where ~ (0, )
. . ~ ( , )
ih h i ih ih h
ih h i h
N
i e N
η λ θ ε ε ψ
η λ θ ψ
= +
 
Where, θ i serves as a composite profile of care rendered by site i. Larger θ i
The parameter λ
 corresponds to better 
quality of health care. 
h is a fixed measure-specific discrimination parameter (weight), 
depending on a measure’s ability to discriminate between sites. It may be thought of as a “factor 
loading” that quantifies the weight of each outcome on the latent variables. The larger the value, 
the more the power to discriminate underlying quality. The sign of λh is not identifiable, so the 
constraint that λh >0 is added to the model. 
    (3.2) 
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The variable εih ~ (0,ψh2
In this hierarchical model, variability in latent quality (θ
 ), the site level random error term  for measure h, measures the 
degree of heterogeneity across sites. 
i) across sites is assumed to have 
both a systematic component, explained by a site-specific covariate (the intervention Xi
 where ~ (0,1)
. . ~ ( ,1)
i i i i
i i
X N
i e N X
θ γ α α
θ γ
= +
: low, 
moderate, high intensity), and a random component such that  
        
where variable iα  is i.i.d error term (i.e. iα  ~ N (0,1)), so that  the prior variance of the latent 
quality trait is set to 1 (to fix the scale of the latent variable for identifiability of the model). 
Estimates of the latent trait (θi.) are given by the posterior mean of θ i
Parameter γ is the vector of fixed treatment effects, γ = (γ
. Low values indicate poor 
quality of care.    
1 , γ2 ) with γ1 denoting 
moderate intensity vs. low intensity, and γ2 denoting high intensity vs. low intensity. The  linear 
contrast γ1 -γ2
Here X
 denotes high intensity vs. moderate intensity. 
i denotes the vector of site-level covariates, Xi = (xi1, xi2
It follows from the two-stage between-site models (specified above in equations 3.2 and 
3.3) that we can formalize the between-site model in one equation 
), where (0, 0) = low 
intensity intervention, (1,0) = moderate intensity intervention, (1,1) = high intensity intervention.  
2
2 2
+ , where ~ (0,1), ~ (0, )
. . ~ ( , )
ih h i h i ih i ih h
ih i h h
X N N
i e N X
η λ γ λ α ε α ε ψ
η γ λ ψ
= +
+
 
Based on the two submodels specified above in equation 3.1 and 3.4, the full model can 
be written as  
 0h 1h 0h 1h ijk ijk ij( | , , , , , , , ) + z + + +ijkh h i ijk ij ih ijk h i ihLogit y zβ β λ θ µ υ ε β β µ υ λ θ ε= +  
      (3.4) 
 
  (3.5) 
 
      (3.3) 
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In matrix form 
[ ]
1 01 111 1
2 02 212 2
13 33 03 3
14 404 44
( )
( )
( )
( )
ijk i
ijk i
ijk i ij ijk
ijk i
iijk
Logit y
Logit y
Z
Logit y
Logit y
β εβ λ
β εβ λ
θ ν µ
β λβ ε
β λβ ε
        
        
        = + + + + +        
        
               
 
             where θi =γXi + ai
                         µ
 as specified in equation 3.3  
ijk ~ N(0, σ2) ,Vij ~ N(0, τ2), εih  ~ N(0, ψh2)
or formalized in one equation 
  
0h 1h 0h 1h ijk ijk ij
22 2
ijk ij
( | , , , , , , , , ) + z + + +
   ~N(0, ), ~ (0, ), ~N(0,1), and ~ (0, )
ijkh h ijk ij ih ijk i h i h i ih
i ih h
Logit y z X X
where N N
β β λ γ µ υ ε β β µ υ λ γ λ α ε
µ σ υ τ α ε ψ
= + +
  
There are a total of 20 unknown parameters in this model for 4 outpatient measures, 
including treatment effect γ(γ1, γ2), measurement specific intercept (β0h), measurement- specific 
factor loading (λh), measurement- specific covariate effect (β1h) ,   and the variance σ2 of the 
patient -level random error term(µijk), the variance τ2of the provider-level random error term(vij) 
and the variance ψh2  of the measurement- specific site-level random error terms (ε ih). A path 
diagram of this model is given in Figure 3-1.  
(3.6) 
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λ1 λ2 λ3 λ4 
Xi (intervention) 
 
γ 
 θi 
 
Yijk1 Yijk2 Yijk3 Yijk4 
ψ1 
 
ψ2 
 
ψ3 ψ4 
 
ηi1 
 
ηi2 
 
ηi3 
 
ηi4 
 
Outcome:Yijkh 
  i: Site  
  j: Provider  
  k: Patient  
  h: Measurements  
µijk Vij 
 
σ2(patient) τ2(provider) 
Site-level random 
effect by measures 
β0h+β1h  Zijk(high-risk)     +   + 
Patient-level 
outcomes 
Site-level latent trait  
 
Site-level intervention effect 
Variance=1 
Between-site 
model 
Within-site 
model 
  Note: The circles represent the latent variable, ellipses represent random effects, rectangles represent the 
 observed data, free-standing letters represent parameters, and the arrows represent linear/non linear 
  relations 
Figure 3-1 Path diagram of one latent trait model with four outcomes 
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3.1.2 Model estimation 
We used a fully parametric Bayesian approach for model estimation. Bayesian estimation of the 
model parameters requires the specification of a prior distribution for each unknown parameter. 
In this study, a noninformative but proper prior distribution is used. We assume that the fixed 
effects ({β0h}, {β1h} and {γ}) are independent and normally distributed with mean zero and a 
huge variance 104 (N (0, 104). The prior distributions for factor loadings {λh} also were chosen 
to be N (0, 104
2 -1p( )σ σ∝
), but truncated below 0 for model identification. For the variance parameters, we 
follow the recommendation of Andrew Gelman (2006) to use a noninformative uniform prior 
density on standard deviation parameters unless a weakly informative prior is desired. The 
uniform density on σ is equivalent to , an inverse χ2 distribution with -1 degree of 
freedom. We used Uniform (0,100) as prior for the standard deviation of σ, τ, and {ψh}  to 
account for clustering at the patient, provider and site levels. The inverse-gamma (ε,ε) family of 
noninformative prior distributions is not recommended here, because when σ is estimated to be 
near zero the resulting inference will be sensitive to ε. The setting of near-zero variance 
parameters is important, partly because this is where the classical and Bayesian inference for 
hierarchical models will differ the most. To identify parameters, we fix the scale of the latent 
variable by setting the variance of the prior distribution for θi
Bayesian estimates of latent variable models can be obtained using MCMC techniques, 
including Gibbs sampler (Geman and Geman, 1984) and the Metropolis Hasting (MH) algorithm 
(Metropolis et al., 1953; Hasting, 1970). The strategy is to treat latent quantities
 equal to 1.  
( )Ω , including 
the latent trait and random effects, as hypothetical missing data; due to the nature of MCMC, it is 
not necessary to integrate out the latent quantities to make inference about the parameters. The 
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latent quantities are updated, along with other parameters from their posterior distributions 
( , | )P yθ Ω by drawing observations iteratively from their full conditional densities ( | , )p yθ Ω  
and ( | , )p yθΩ . For the proposed model specified by equations (3.1-3.6), the augmented 
complete data likelihood function takes the form: 
32 4
0 1 0h 1h
1 1 1 1
4
0h 1h ijk ij
1 1 1
( , | , , , , , , , , ) ( , , , , | , , , , , , , )
 = ( | , , , , , , ) ( ;0, ) ( ;0, )
ij ijk
ij ijk
n n
ijkh i ijk ij ih h ijk i
i j k h
n n
ijkh i ijk ij ih
j k h
f Y Z X f y z X
f y
β β λ γ σ τ ψ θ µ υ ε β β λ σ τ ψ
β β λ θ µ υ ε φ µ σ φ υ τ
= = = =
= = =
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   
        
∏∏∏∏
∏ ∏ ∏
32 4
ih
1 1
32 4
0h 1h ijk ijk ij h i ih
1 1 1 1 0h 1h ijk ijk ij h i ih
132
22
ijk
1 1 1 1
( ; ' ,1) ( ;0, ) 
exp{ ( + z + + + + )}
1 exp{ ( + z + + + + )}
1 1 1 ( ) exp{ ( ) }  (
2
ij ijk
ij ijk
i i h
i h
n n
ijkh
i j k h ijkh
n n
i j k j
X r
y
y
φ θ φ ε ψ
β β µ υ λ θ ε
β β µ υ λ θ ε
µ
σ σ τ
= =
= = = =
= = = =

∝
+
× ×
∏ ∏
∏∏∏∏
∏∏∏
132
22
ij
1
132 32 4
2 22
1 1 1
1) exp{ ( ) }
2
1 1 1  exp{ ( ) } ( ) exp{ ( ) }
2 2
ijn
i
i i ih
i i h h h
X
ν
τ
θ γ ε
ψ ψ
=
= = =
× − − ×
∏∏
∏ ∏∏
  
Given the augmented complete data likelihood in (3.7) and priors specified as above, the joint 
posterior of latent quantities and all unknown parameters can be expressed as 
0 1
0h 1h 0 1
4
0h 1h ijk ij
1 1 1
( , , , , , , , , , , | , , )
  { ( , , , , | , , , , , )} ( , , , , , , )
   = { ( | , , , , , , ) ( ;0, ) ( ;0, )
ij ijk
i ijk ij ih
ijkh i ijk ij ih h
n n
ijkh i ijk ij ih
j k h
f Y X Z
f y f
f y
β β λ γ σ τ ψ θ µ υ ε
θ µ υ ε β β λ σ τ ψ β β λ γ σ τ ψ
β β λ θ µ υ ε φ µ σ φ υ τ
= = =
∝
  
     
∏
∏ ∏ ∏
32 4
ih
1 1
0 1
( ; ' ,1) ( ;0, ) }
      ( , , , , , , )
i i h
i h
X r
f
φ θ φ ε ψ
β β λ γ σ τ ψ
= =
 
  
 
×
∏ ∏
  
The parameters are sampled using the augmented data. The full conditional distributions 
needed to implement the MCMC algorithms are summarized below: 
(1) Sample iθ using the Metropolis algorithm from the full conditional distribution:    
(3.7) 
(3.8) 
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0h 1h ijk ijk ij h i ih
0 1
+ z + + + +
0h 1h ijk ijk ij h i ih
1
2
( | . ) ( | , , , , , ) ( | )
            ex { [ ( + z + + + + )-log(1+e )
1                       - ( ) }
2
i ijk i
h
ijk
k
i i
Pr Pr y p
p y
rX
β β µ υ λ θ ε
θ β β λ σ τ ψ θ γ
β β µ υ λ θ ε
θ
=
∝
∝
−
∑  
(2) Sample random effects of ijkµ , ijυ , ihε using rejection sampling (Zeger and Karim 
1991)  
(3) Sample variance of random effects using inverse gamma distribution 
      
2
2 0.010.01( | .) ( , )
2 2
ijkIf IG
µ
σ
 ++
∝   
 
∑ , similarly for 2τ and 2hψ  
 (4) Sample 0 1( , , )h h h hβ β β γ  using the metropolis algorithm from the full conditional 
distribution: 
      
32
10h 1h ijk ij h i ih
1 1 1 0h 1h ijk ijk ij h i ih
exp{ ( + z ++ + + )} 1( | .) exp( ' )
1 exp{ ( + z + + + + )} 2
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(5) Sample γ  using the full conditional distribution: 
       1 1( | .) (( ` ) ` ), ( ` ) )p N X X X X Xγ θ− −∝  
The Gibbs sampler algorithm proceeds by sampling latent quantities and parameters from 
(1) to (5), respectively. The simulation of observations from the standard distributions involved 
in equations for steps 3 and 5 is straightforward. The MH algorithm could be used to simulate 
observations from the remaining complex distributions. Repeat Steps (1)-(5) until convergence 
and collect a large number of additional draws from which to calculate posterior summaries.  
 The generic Bayesian Package WinBUGS1.4 (Spiegelhalter, Thomas, Best and Lunn, 
2003) was used to perform MCMC simulations of the posterior distribution. For our model, we 
used double chains with two sets of varied initial values. In one set we specify 0 as initial values 
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for the fixed effects ({β0h}, {β1h), {γ} and {λh})   and 1 as the initial value for the standard 
deviation parameters (σ, τ, and {ψh}). 
 The Bayesian estimates of posterior mean, standard deviation, median and 95% 
credible intervals were summarized for the final model. To visualize the association between 
each outcome and the latent trait (θ
In another set of initial values, we changed the setting for 
the fixed effects by using the estimates from the preliminary analysis of aggregated site-level 
data. The convergence of the MCMC sampler was assessed by examining trace plots.  
i
ijkhY
), we plot the estimated probability of receiving a process of 
care ( ) as a function of the latent trait ( iθ ).The parameters characterizing these curves, 
0hβ quantify the intercepts, and λ  h
                                           
 quantifies the steepness of the curve.   
0h
ijkh
0h
exp( )Pr (Y =1)=  
1 exp( )
h i
h i
β λ θ
β λ θ
+
+ +
 
We also estimated the relative contribution of the common variance to total variance of 
each outcome as 2 2 2/( )h h hλ λ ψ+ , where hλ  is the outcome-specific factor loading, and 
2
hψ  is the 
site-level outcome specific variance. Pairwise Spearman correlation coefficients for the site-level 
proportion of each individual outcome, the site-level average proportions of the 4 outcomes 
(AVG), and the estimated latent scores ( iθ ) summarize the relationship between observed 
outcomes and the estimated latent scores. Scatter plots of the latent scores vs. site-level average 
outcomes are graphed by intervention arm. 
3.1.3 Model comparison and fit 
We fit other reduced models: one imposing the constraint that the variability in the latent trait 
(θi) across sites is not related to the intervention, but represented by a random component such 
(3.9) 
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that θi ~ N (0, 1); and another model constraints that β1
D pD+
=0, because the poor correlation between 
oxygen assessment (outcome 1) and other outcomes suggests this outcome might measure a 
different underlying construct. The deviance information criterion (DIC) (Spiegelhalter et al., 
2002) was computed as an overall measure of model fit to compare models, with smaller DIC 
being better. The DIC is computed as , where D  
is the posterior mean of the deviance 
and pD is a complexity term that estimates the effective number of parameters in complex 
hierarchical models, computed as the difference between D and the deviance evaluated at the 
posterior mean of the model parameters.  
But does the model fit the data? Global goodness of fit of the final models was assessed 
using posterior predictive checks (Gelman et al., 1995, Loannis 2009) comparing the observed 
data with data replicated under the model. Let 1( ,..., )h
rep rep rep
h h k hy y y=  represent the vector of the 
replicated data for the hth outcome. The distribution of yhrep
1( | ( ,..., )) ( | ) ( | )h
rep rep
h h k h h hp y y y p y w p w y d w= ∫
 given the observed data is 
                                                                     
 
where w is the vector of the model parameters in (3.6). Sampling from (3.10), we 
replicated 2000 data sets given the model in (3.6). We calculated the empirical distribution for 
several summary statistics ( )v hT y for each replicated data set 
rep
hy , and compared them with the 
statistics in the observed data set. ( )v hT y was chosen here as the proportion of patients receiving 
a recommended process of care by intervention group. The choice of this summary statistic was 
motivated by the main study interest of evaluating an intervention effect. We report Bayes p-
values, estimated using tail area probabilities, by the proportion of times the statistics in the 
replicated data were more extreme than the observed one, i.e., Bayes p-values= 
Pr( ( ) ( ) | )repv h v hT y T y w≥ .  Bayes p-values were computed for each ( )
rep
v hT y  across intervention 
(3.10) 
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groups. P-values that are close to 0 or 1 are indicative of poor model fit. Values around 0.5 
indicate that the distributions of the replicated data and the observed data are close. 
3.2 EXTENSION TO THE TWO-LATENT TRAIT MODEL 
EDCAP outpatient data and inpatient data with eight outcomes were used to illustrate the 
proposed method. Because of the structural relationships (structural missing) among outcomes at 
patient level (e.g., outcomes of outpatient care are measured only on patients who were assigned 
to outpatient care, and outcomes of inpatient care are collected only for inpatients), let 
Yijkh,out=(yijk1, yijk2, yijk3, yijk4) denote a vector of outpatient outcomes, and Yijkh,in =(yijk5, yijk6, 
yijk7, yijk8
Instead of modeling outpatient outcomes and inpatient outcomes by two separate one 
latent variable models, here we model all the comes in one model framework using two latent 
trait model, with one trait representing quality of outpatient care and the other one representing 
quality of inpatient care. Assuming the eight measures all were used in the full model, the 
covariance structure of the two traits can be assessed. 
) denote a vector of inpatient outcomes.  Please note that each patient has only four 
outcomes either from outpatient care or inpatient care, due to the structural missing. 
Within-site Model. Model specification is same as (3.1), but with separate equations for 
outpatient care and inpatient care due to the structural missing of outcomes at the patient level. 
Let , ,,i out i inθ θ  denote the outpatient and inpatient traits, respectively. Based on the results from 
the one latent trait models, different patient level random effects and the same provider effect 
were specified for the following two equations. The same provider could be admitting some 
patients and treating others as outpatients. 
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, 0h 1h , 0h 1h ijk ijk,out ij( | , , , , , ) + z + +ijkh out ijk out ij ih ijk ihLogit y zβ β µ υ η β β µ υ η= +                
, 0h 1h , 0h 1h ijk ijk,in ij( | , , , , , ) + z + +ijkh in ijk in ij ih ijk ihLogit y zβ β µ υ η β β µ υ η= +  
We combine the two equations in (3.11) using an indicator variable of outp with 1 
indicating that the patient was assigned to outpatient care and 0 indicating that the patient was 
assigned to inpatient care. 
             0h 1h , ,
outp 1-outp
0h 1h ijk , , ij
( | , , , , , , )
                 + z +( ) ( ) +
ijkh ijk out ijk in ij ih ijk
ijk out ijk in ih
Logit y zβ β µ µ υ η
β β µ µ υ η= +
 
In (3.12), 2ijk,out ~N(0, )outµ σ  and
2
ijk,in ~N(0, )inµ σ  denote outpatient and inpatient patient-level 
random effects respectively, 2ij ~ (0, )Nυ τ is the provider-level random effect, and εih ~ (0, ψh
2) 
is site-level outcome-specific random effect. The site-level random effect (ηih ) 
Between-Site Model (for extension to two latent traits). Assume there are M traits, here 
M=2 here. We relate the 8 site-level random effects to a vector (L=2) of latent variables, θ
is specified in 
between-site model as follows: 
i = 
(θ1i, θ2i
2 2
1 1 2 2| , , ~ ( , )ih i h h h hi iNη θ λ λ θ λ θΨ + Ψ
).  
 
Where 1 2  i iandθ θ  denote the outpatient trait and inpatient trait for site i, respectively. 
Here, λ  is a 2 X 8 vector of discriminating parameters that account for the correlation 
among the eight measures. The 8 measurement-specific random effects at the site level were 
partitioned into two factors, representing the quality of each trait separately, by fixing certain 
elements of λ equal to 0. The model identification is achieved by anchoring, where we scale each 
factor by setting one factor loading to specify the ”scale” of the unknown parameters  
(3.11) 
 
(3.12) 
 
(3.13) 
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As in the one latent trait model, variability in a latent quality (θmi) across sites is assumed 
to have both a systematic component, explained by site-specific covariates (here the randomized 
intervention Xi
1 2( , ) ~ ( ` ,  )i T ii i N X Rθ θ θ= Σ
: low, moderate, high intensity intervention), and a random component such that  
 
Where 1, 2,
1, 2,
 
  
out out
in in
r r
R
r r
 
=  
 
 is a 2 X 2 vector representing outpatient and inpatient intervention 
effects of moderate intensity vs. low-intensity, and high-intensity vs. low-intensity interventions, 
respectively. 11 12
21 22
 
 
φ φ
φ φ
 
Σ =  
 
 denotes a covariance matrix of the two latent variables.  
Formulating the model in equation (3.15) in matrix form, parameters with asterisks are 
parameters that are fixed at the preassigned values. 
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The augmented complete data likelihood function takes the form: 
0 1
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A path diagram is shown in Figure 3-2 for eight outcomes with two latent traits, and four 
outcomes for each trait. 
A Wishart (R, r) prior was specified for the covariance matrix Ω. To represent a non-
informative prior, we chose a large number of degrees of freedom (r=8). The scale matrix was 
specified as 
1 0
0 1
R  =  
 
(Lee and Song 2003). The priors for other parameters were specified as in 
section 3.1.2. 
(3.16) 
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Outcome:Yijkh 
i: site  
j:Provider  
k: patient  
h: measure  
µijk vij 
 
σ2 (patient) τ2 (provider) 
Site-level random 
effects   
 
β0h+β1h  Zijk(high-risk) 
 
      +   + 
Patient-level 
outcomes 
 
Site-level latent traits  
 
Site-level intervention effects 
 
Note: The circles represent latent variables, ellipses represent random effects, rectangles represent the 
observed data, free-standing letters represent parameters, and arrows represent linear/non linear relations 
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Figure 3-2 Path diagram of two latent trait model with eight outcomes, and four outcomes for each trait 
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4.0  ONE-LATENT TRAIT MODEL FOR MULTIPLE BINARY OUTCOMES IN A 
CLUSTER RANDOMIZED CLINICAL TRIAL 
4.1 ABSTRACT 
In clinical trials, multiple endpoints for treatment efficacy often are obtained, and in addition, 
data may be collected hierarchically. Statistical analyses become very challenging for such 
multidimensional hierarchical data, particularly with data collected at more than two levels. We 
propose a latent variable approach to construct an underlying latent trait from the multiple binary 
outcomes for a three-level model with multiple outcomes at the patient-level and clustering at the 
provider and site levels, and assess an intervention effect on the latent trait directly.  Random 
effects model the hierarchical structure, and the parameters are estimated using a fully Bayesian 
approach. We illustrate the proposed approach in a cluster randomized clinical trial with four 
binary outcomes. Simulation studies are conducted to check the algorithm and computational 
implementation. This latent variable modeling approach incorporates the correlation structure 
into a single latent outcome, and simultaneously regresses the latent outcome on observed 
covariates. It provides a comprehensive alternative to individual outcomes analysis of 
multivariate and hierarchical data versus traditional individual outcome analysis, and leads to an 
intuitively appealing and useful interpretation of complex data.   
Key Words: Latent variable models, hierarchical models, Bayesian approach  
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4.2 INTRODUCTION 
In clinical trials, multiple endpoints for treatment efficacy often are obtained (Pocock, Geller, 
and Tsiatis, 1987). The primary objective of analyses of this kind may not be to identify which 
particular outcomes differ by groups, but rather to use all the data at hand to establish whether 
there is a difference between the groups. Several statistical issues arise in evaluating a treatment 
effect from this type of data. Multidimensionality is a major issue, because several response 
variables measure slightly different aspects of the effect of interest, and no single response 
variable suffices as the main outcome variable. Methods that collectively consider all of the 
response variables are desirable (Gray and Brookmeyer, 1998). When data are collected 
hierarchically, the outcomes are both multidimensional and hierarchical. These methods also 
must account for the autocorrelation between observations within the same cluster and the cross-
correlation between different response variables both across and within clusters. Frequently, 
there is a need to summarize all of the multidimensional outcomes into a unidimensional 
composite score, such as an overall measure of quality of care in health care research (Teixeira-
Pinto and Normand 2008).  
Commonly used approaches include individual outcome data analysis, dimension 
reduction, and global test procedures. Each of these approaches fails to characterize relationships 
between outcomes or summarize those variables. Individual outcome data analysis (i.e., analyze 
each  outcome separately and present multiple P-values) is simple and easy to implement, but 
fails to provide an overall estimate of the treatment effect, increases the overall Type I error rate, 
and does not borrow strength across the response variables. Dimension reduction approaches, 
such as calculating a summary score for several continuous variables, collapsing multiple binary 
outcomes into a single binary outcome, or constructing a complex function of the individual 
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response variables such as principal components (Morrison, 1976), may result in biased 
estimates and a loss of information. Furthermore, data reduction may lead to uninterpretable 
results, and uncertainty in the aggregated scores is difficult to quantify (Gray and Brookmeyer, 
1998). Global testing procedures for multiple outcomes described by O’Brien (1984), Pocock 
(1987) and Legler (1995) among others, including generalized estimating equation (GEE) based 
score tests for general M-group comparisons, could be used to assess whether groups differ with 
respect to multiple outcomes.  However such methods do not characterize the relationships 
between outcomes (Sammel, Ryan and Legler 1997).  
Latent variable models (i.e., models that include the random unobserved variables) 
provide a natural way to analyze such complex multivariate data. (Skrondal and Rabe-Hesketh 
2004). The model framework incorporates the correlation structure into a single latent outcome, 
which is a weighted combination of the observable outcomes, and simultaneously regresses the 
latent outcome on observed covariates. One advantage of the latent variable model is that a one 
degree-of-freedom likelihood ratio test of the overall covariate effect could be more powerful 
than a M degree-of-freedom test (Sammel 1999). Another advantage is that a summary latent 
score for each individual is estimated as a by-product, such as computing an individual severity 
score in birth defect study (Legler and Ryan, 1997).    These models have been employed 
extensively in psychological and educational testing (Baker 1992) and the social sciences (Eye 
and Clogg, 1994). In recent years, use of latent variable models has been increasing in medical 
and public health research (Legler and Ryan, 1997; Sammel, Ryan, and Legler, 1997; Teixeira-
Pinto and Normand, 2008). However, latent variable models seldom have been used to test 
hypotheses about clinical outcomes in clinical trials and other designed studies (Donaldson 
2003). 
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Most of the literature on latent variable models is frequentist in nature, based on 
maximum likelihood estimation. Computation is intensive and difficult, because in general no 
closed form exists for the multi-dimensional integrals. Compared to maximum likelihood 
methods, Bayesian alternatives using Markov Chain Monte Carlo (MCMC) are becoming more 
popular and attractive because of their flexibility (Lee and Song 2004, Lee and Song 2003, 
Dunson et al. 2003). MCMC incorporates prior information and, under specification of a flat 
(non-informative) prior, provides estimates similar to those obtained by maximum likelihood as 
well as interval estimates that can be obtained directly from the posterior samples. The 
difficulties induced by the complexities of the multi-dimensional integrals can be handled 
efficiently by powerful computing tools, such as the Gibbs sampler. Samples available from the 
joint posterior distribution of the latent variables can be used flexibly to identify outlying 
subjects and to obtain important insights into structural relationships (Sik-Yum Lee 2007).  
In this paper, we outline a general latent variable model for multiple binary outcomes 
from a 3-level cluster-randomized clinical trial using a fully Bayesian approach, to evaluate an 
overall intervention effect with multivariate outcomes at the patient level. In Section 4.3, we 
present the motivating example of the EDCAP trial (Yealy et al., 2004). In Section 4.4, we 
describe a Bayesian formulation of the proposed model and the implementation in WinBUGS 1.4 
(Windows version of Bayesian inference Using Gibbs Sampling, Gilks 1994) to estimate the 
parameters. In Section 4.5, we illustrate the proposed methodology using the EDCAP data.  We 
check the algorithm and our computational implementation with simulations in Section 4.6, and 
conclude with a discussion in section 4.7.  
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4.3  MOTIVATING EXAMPLE: THE EDCAP STUDY 
The cluster-randomized EDCAP study was designed to compare the effectiveness and safety of 
three guideline implementation strategies of increasing intensity (low-intensity, moderate-
intensity, and high-intensity) on quality of care of CAP in EDs (Yealy et al., 2004). The low-
intensity implementation arm reflected the quality improvement methods typically used by the 
collaborating state quality improvement (QI) organizations, which served as a usual care control. 
The moderate intensity arm also conducted an on-site educational session for ED medical 
providers and requested a QI plan for the admission decision. The high-intensity intervention 
also conducted a multifaceted set of provider behavior change techniques (i.e. reminder form, 
feedback, and bimonthly plan-do-study-act cycles) that continued through the year-long 
guideline implementation period. The intervention was randomized at the site (ED) level. This 
study has a 3-level hierarchical data structure, in which multiple outcomes are nested within 
patients, patients are nested within providers, and providers are nested within clinical sites.   
For patients assigned to outpatient care, the study practice guideline recommended four 
processes of outpatient care in the ED:  oxygen assessment, first dose of antibiotics in ED, 
treatment with compliant antibiotics in the ED, and compliant antibiotic therapy upon discharge. 
The 1125 patients assigned to outpatient care were seen by 310 providers at 32 clinical sites. 
Each patient had four binary outcomes, with 1 indicating that the patient received the 
recommended process of care, 0 otherwise. Scatter plots of the site-level average outcomes 
(proportions of outpatients receiving recommended processes of care) by intervention arm are 
shown in Figure 4-1. In general, sites with higher intensity interventions had higher proportions 
of patients receiving the recommended processes of care. Oxygen assessment had a ceiling 
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effect, with little variability across sites. Site-level descriptive statistics are summarized in Table 
4-1. 
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Figure 4-1  Site-level average outcomes (i.e., proportions of outpatients receiving each recommended process of 
care) by intervention arm 
 
Table 4-1 Site-level averaged proportions of patients receiving each recommended process of care 
Variable 
Low 
intensity 
intervention 
% 
N=174 
Moderate 
intensity 
intervention 
% 
N=498 
High 
intensity 
intervention 
% 
N=453 
Oxygen assessment 95.7 ( 4.1) 94.6 ( 7.5) 96.9 ( 3.4) 
First dose antibiotics in ED 64.8 ( 9.4) 70.8 (18.2) 90.6 ( 5.7) 
Compliant ED antibiotics 29.0 (13.4) 35.4 (23.1) 63.7 ( 5.4) 
Complaint discharge antibiotics 79.1 ( 8.9) 90.0 ( 5.0) 89.4 ( 8.1) 
 
Estimated intervention effects from an individual outcome analysis are summarized in 
Table 4-2. We ran separate random effect logistic regression models to estimate the log odds of a 
patient receiving each recommended process of care as a function of intervention arm, adjusting 
for patient risk status (low risk vs. high risk) and accounting for clustering at both the provider 
level and the site level.  Models were fit using GLAMM in Stata 10. In total, 12 pairwise 
Oxygen assessment                             First dose of antibiotics in 
ED      
Treatment with compliant 
antibiotics therapy in ED 
Compliant antibiotic 
therapy on discharge 
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comparisons were conducted for the 4 individual outcomes across 3 intervention arms. Type I 
error is increased with all of these univariate analyses. Only the intervention effects of the first 
dose of antibiotics and compliant antibiotic therapy in the ED reached statistical significance 
once the multiple testing was taken into account using a Bonferroni correction (Miller, 1981). 
Most importantly, an overall intervention effect cannot be estimated. 
Table 4-2 Estimated intervention effects from univariate random effect logistic regression models 
Variable 
Moderate vs. low 
intensity intervention 
Log OR (95% CI) 
High vs. low 
intensity intervention 
Log OR (95% CI) 
High vs. moderate 
intensity intervention 
Log OR (95% CI) 
Overall 
P value 
 
Oxygen assessment 0.10 (-1.09, 1.29) 0.40  (-0.82, .63) 0.30  (-0.73, 1.34) 0.78 
First dose antibiotic in ED 0.26  (-0.50, 1.01) 1.90 (1.08, 2.72) 1.65  (0.92, 2.37) <0.001 
Compliant ED antibiotic 0.19 (-0.66, 1.04) 1.78 (0.93, 2.64) 1.59 (0.86, 2.33) <0.001 
Complaint discharge antibiotic 0.77 (0.08, 1.47) 0.99 (0.28, 1.70) 0.22  (-0.41, 0.85) 0.02 
4.4  LATENT VARIABLE MODEL 
We describe our method in the context of EDCAP example. Let Yijkh (1 = received 
recommended procedure; 0 = not) be the dichotomous outcome of the hth response (h=1,2,3,4, 
where the four responses are ordered as: oxygenation, timely antibiotic, compliant ED antibiotic, 
compliant discharge antibiotic) of the kth (k=1,2,…nij) patient treated by provider j (j=1,2,…ni) 
in the ith (i=1,2…32) site (ED), Xi{(xi1, x i2) (0,0)=low intensity, (1,0)=moderate intensity, 
(1,1)=high intensity)} denote the site-level intervention arms, and Zijk (0=low risk, 1=high risk) 
be the covariate of patient-level risk status. The proposed latent approach is a comprehensive, 
simultaneous model. We formalize the likelihood function by writing the within-site and 
between-site models sequentially, with the within-site model linking the outcomes to  patient risk 
status and various random effects, and the between-site model linking the site-level random 
 44 
effect to the latent variable, with the latent mean modeled as a function of the intervention. In 
this example, the underlying site-level latent variable can be considered as a hypothetical 
construct of “quality of outpatient pneumonia care in ED”. 
4.4.1  Model specification 
Within-Site Model. Each outcome is assumed to follow a binomial distribution and is linked by 
logit link to the patient-level covariates, a patient-level random effect, a provider-level random 
effect, and a site-level outcome-specific random effect: 
0h 1h 0h 1h ijk ijk ij( | , , , , , ) + z + + +ijkh ijk ij ih ijk ihLogit y zβ β µ υ η β β µ υ η=            
In (4.1), β0h  denotes a baseline for each outcome, indicating performance of the  hth  
process of  care at an average site with the low-intensity intervention for low risk patients, and 
β1h denote a fixed outcome-specific regression coefficients for a patient-level covariate, risk 
status (Zijk
2
ijk ~N(0, )µ σ
). We model the correlation between the four outcomes with a patient-level random 
effect , and the correlation between patients within providers with a provider-level 
random effect 2ij ~ (0, )Nυ τ . The ηih denote outcome-specific site level random effects for 
outcome h at site i, permit heterogeneity across the sites, and allow for correlation between 
patients within a site. The random effects µijk, νij, and η ih are assumed 
Between-Site Model. To model the correlation between the multivariate outcomes at the 
site-level, we relate the site-level random effects to one latent variable θ
to be mutually 
independent. 
i, such that the four site-
level effects are conditionally independent given the latent variable θi. 
(4.1) 
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2
2
,  where ~ (0, )
. . ~ ( , )
ih h i ih ih h
ih h i h
N
i e N
η λ θ ε ε ψ
η λ θ ψ
= +
 
Here θi serves as a composite profile of outpatient care rendered by site i, with larger 
values denoting better quality of care. In (4.2), λh is fixed outcome-specific discrimination 
parameter (weight), which quantifies the weight of each outcome on the latent variables and 
indicates the ability of each outcome to discriminate between sites.  Larger values for λh 
correspond to outcomes that better discriminate the underlying quality of care between sites. The 
sign of λh is not identifiable, so the constraint that λh >0 is added to the model.  The ε ih ~ (0, 
ψh2
In this hierarchical model, variability in latent quality (θ
) denote site level random error terms for outcome h, and quantify the degree of 
heterogeneity across sites. 
i) across sites is assumed to have 
both a systematic component, explained by the site-level interventions (Xi
                                    
), and a random 
component such that  
 where ~ (0,1)
. . ~ ( ,1)
i i i i
i i
X N
i e N X
θ γ α α
θ γ
= +
 
Where ai~ N(0,1) 

iθ
 is i.i.d error term. The prior variance of the latent quality trait is set to 1, to fix 
the scale of the latent variable for identifiability of the model (Skrondal & Rabe-Hesketh 2004). 
Estimates of the latent score ( ) are given by the posterior mean of θ i, where low values for the 
latent score indicate poor quality of care. In (4.3), γ (γ1 , γ2 ) is the vector of fixed treatment 
effects on latent mean, with γ1 denoting moderate intensity vs. low intensity, and γ2
Equations 4.2 and 4.3 can be combined to formalize the between-site model in one 
equation: 
 denoting 
high intensity vs. low intensity  respectively. 
    (4.2) 
 
 (4.3) 
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2
2 2
+ , where ~ (0,1), ~ (0, )
. . ~ ( , )
ih h i h i ih i ih h
ih i h h
X N N
i e N X
η λ γ λ α ε α ε ψ
η γ λ ψ
= +
+
 
Combining equations 4.1 and 4.4, the full model can be expanded as: 
0h 1h 0h 1h ijk ijk ij( | , , , , , , , ) + z + + +ijkh h i ijk ij ih ijk h i ihLogit y zβ β λ θ µ υ ε β β µ υ λ θ ε= +  
In matrix form 
[ ]
1 01 111 1
2 02 212 2
13 33 03 3
14 404 44
log ( )
log ( )
log ( )
log ( )
ijk i
ijk i
ijk i ij ijk
ijk i
iijk
it y
it y
Z
it y
it y
β εβ λ
β εβ λ
θ ν µ
β λβ ε
β λβ ε
        
        
        = + + + + +        
        
               
 
                                Wwhere ~ ( ,1)i iN Xθ γ  as specified in equation (3.3).  
The combined equation can be written as: 
       0h 1h 0h 1h ijk ijk ij
22 2
ijk ij
( | , , , , , , , , ) + z + + +
   ~N(0, ), ~ (0, ), ~N(0,1), and ~ (0, )
ijkh h ijk ij ih ijk i h i h i ih
i ih h
Logit y z X X
where N N
β β λ γ µ υ ε β β µ υ λ γ λ α ε
µ σ υ τ α ε ψ
= + +
 
A total of 20 unknown parameters appear in this model for four outcomes from 3-level 
hierarchical data, , including the treatment effect  γ(γ1, γ2), outcome-specific intercept (β0h) , 
outcome-specific factor loading (λh ), outcome-specific covariate effect  (β1h) ,   and the variance 
σ2 of patient-level random error term (µijk), the variance τ2 of provider-level random error term 
(vij) and the outcome- specific variance ψh2  of site-level random error terms (εih).  To better 
visualize this complicated model, a path diagram is shown in Figure 4-2.  
 
 
  (4.4) 
 
    (4.5) 
 
 (4.6) 
 
 47 
 
λ1 λ2 λ3 λ4 
Xi (intervention) 
 
 
 θi 
 
Yijk1 Yijk2 Yijk3 Yijk4 
 
 
 
 
  
 
ηi1 
 
ηi2 
 
ηi3 
 
ηi4 
 
Outcome: yijkh 
  i: Site  
  j: Provider  
  k: Patient  
  h: Measurements  
µijk Vij 
 
σ2(patient) τ2(provider) 
Outpatient care- 
specific site-level 
random effects  
β0h+β1h  Zijk(high-risk)     
+ 
 
+ 
Patient-level 
outcomes 
Site-level latent trait  
 
Site-level intervention effect 
Variance=1 
Between-site 
model 
Within-site 
model 
Note: The circles represent latent variable, ellipses represent random effect, rectangles represent the 
observed data, free-standing letters represent parameters, arrows represent linear/non linear relationships, 
and short arrows pointing at circles or rectangles represent residual variability. 
Figure 4-2 Path diagram of one latent trait model 
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4.4.2    Model estimation 
Bayesian estimation of the model parameters requires the specification of a prior distribution for 
each unknown parameter. For the fixed effects ({β0h}, {β1h} and {γ}), we use diffuse priors, 
independent normal distributions with mean zero and large variance (104), respectively. The 
prior distribution for factor loading {λh} also was chosen to be N (0, 104), but truncated below 0 
for identification. For the variance parameters, we followed the recommendation of Gelman 
(2006) to use a noninformative uniform prior density on standard deviation (SD) parameters in 
hierarchical models. The uniform (0,100) was used as prior for σ, τ, and {ψh}, the SDs of 
random effects at the patient, provider and site level, respectively. We assume that the prior 
distributions of all these parameters are independent, and for each of these parameters, diffuse 
priors lead to equally probable a priori for all possible values and hence proportional to a 
constant (Choi K and Seltzer M, 2010). To identify parameters, we fix the scale of the latent 
variable by setting the variance to 1 for the prior distribution of θi
Bayesian estimates of latent variable models can be obtained using MCMC techniques, 
including Gibbs sampler (Geman and Geman, 1984) and the Metropolis Hasting (MH) algorithm 
(Metropolis et al., 1953; Hasting, 1970). The strategy is to treat latent quantities
. 
( )Ω , including 
the latent trait and random effects, as hypothetical missing data; due to the nature of MCMC, it is 
not necessary to integrate out the latent quantities to make inference about the parameters. The 
latent quantities are updated, along with other parameters from their posterior distributions 
( , | )P yθ Ω by drawing observations iteratively from their full conditional densities ( | , )p yθ Ω  
and ( | , )p yθΩ . For the proposed model, the augmented complete data likelihood function takes 
the form: 
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0 1 0h 1h
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The generic Bayesian Package WinBUGS1.4 (Spiegelhalter, Thomas, Best and Lunn, 
2003) was used to perform MCMC simulations of the posterior distribution. For our model, we 
used double chains with two sets of varied initial values. The convergence of the MCMC 
sampler was assessed by examining trace plots.  
We fitted two reduced models: one imposing the constraint that the variability in the 
latent trait (θi) across sites is not related to the intervention, but only represented by a random 
component such that θi ~ N (0, 1); and one imposing the constraints that β1
The Bayesian estimates of the posterior means, standard deviations, medians and 95% 
credible intervals were summarized for the final model. To visualize the association between 
each outcome and the latent trait (θ
=0, because the poor 
correlation of oxygen assessment (outcome 1) with the other outcomes suggests that this outcome 
might measure a different underlying construct. The deviance information criterion (DIC) 
(Spiegelhalter et al., 2002) was computed as an overall measure of model fit in model 
comparison with smaller DIC being better.  
i), we plot the estimated probability of receiving a process of 
 
    (4.7) 
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care ( ijkhY ) as a function of the latent trait ( iθ ). The parameters characterizing these curves, β0h 
quantify the intercepts, and λ  h
                                           
 quantifies the steepness of the curve.   
0h
ijkh
0h
exp( )Pr (Y =1)=  
1 exp( )
h i
h i
β λ θ
β λ θ
+
+ +
 
We also estimated the relative contribution of the common variance to total variance of 
each outcome as 2 2 2/( )h h hλ λ ψ+ , where hλ  is the outcome-specific factor loading, and 
2
hψ  is the 
site-level outcome specific variance. Pairwise Spearman correlation coefficients for the site-level 
proportion of each individual outcome, the site-level average proportions of the 4 outcomes, and 
the latent score ( iθ ) summarize the relationship between observed outcomes and the estimated 
latent score. Scatter plots of the latent score vs. site-level average outcomes are graphed by 
intervention arm. 
Global goodness of fit of the final models was assessed using posterior predictive checks 
(Gelman et al., 1995, Loannis 2009), comparing the observed data with data replicated under the 
model. Let 1( ,..., )h
rep rep rep
h h k hy y y=  represent the vector of the replicated data for the h
th outcome. 
The distribution of yhrep
1( | ( ,..., )) ( | ) ( | )h
rep rep
h h k h h hp y y y p y w p w y d w= ∫
 given the observed data is 
                                                                     
 
Where w is the vector of the model parameters in (4.6). Sampling from (4.10), we replicated 
2000 data sets given the model in (3.6). We calculated the empirical distribution for several 
summary statistics ( )v hT y for each replicated data set 
rep
hy , and compared them with the statistics 
in the observed data set. ( )v hT y was chosen here as the proportion of patients receiving a 
recommended process of care by intervention group. The choice of this summary statistic was 
motivated by the main study interest of evaluating intervention effect. We report Bayes p-values, 
(4.9) 
(4.10) 
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estimated using tail area probabilities, by the proportion of times the statistics in the replicated 
data were more extreme than the observed one, i.e. Bayes p-values= Pr( ( ) ( ) | )repv h v hT y T y w≥ .  
Bayes p-values were computed for each ( )repv hT y  across intervention groups. P-values that are 
close to 0 or 1 are indicative of poor model fit. Values around 0.5 indicate that the distributions 
of the replicated data and the observed data are close. 
4.5 APPLICATION TO THE EDCAP OUTPATIENT DATA 
We applied the proposed approach using outpatient data from the EDCAP trial to assess whether 
site-level quality of outpatient pneumonia care varied systematically by intervention arm. In 
total, 20 parameters are estimated in equation 3.6. Our parameter estimates were based on the 
output of a Gibbs sampler of 7000 iterations after eliminating the first burn-in 3000 iterations 
(double chains). All the results are based on the pooled two chains, that is, a sample size of 
14,000 deviates. The full model with an intervention effect on the latent trait is preferred because 
the full model clearly shows that the latent trait varies systematically by intervention arm, 
although the difference in DIC between the two models was small (model with intervention 
effect: DIC=3211, model without intervention effect: DIC=3215). This is not surprising because 
the two models differ only in the latent structure at the site level, and only 32 sites are available 
to test the model fit. The model with “oxygen assessment” removed from the latent trait had 
slightly higher DIC (3212) than the full model with intervention effect. For comparable 
interpretation of the four outcomes, we choose to maintain oxygen assessment in the final model. 
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Posterior summaries of selected parameters characterizing the hierarchical structure and 
relationships between intervention and outcomes are shown in Table 4-3. The larger the intercept 
(β0h), the higher the proportion of patients received the therapy on average. Oxygen assessment 
has best average performance, and treatment with compliant antibiotic therapy in ED had the 
poorest average performance. Two outcomes of first dose of antibiotics in ED and treatment with 
compliant antibiotic therapy in ED had relatively large values of the discrimination parameter 
(λh
The intervention effect was modeled indirectly on the site-level latent trait (θ
), indicating those two therapies had larger variability across sites and potentially more 
discriminatory power for site performance (and more weight on the latent trait). The data show 
obvious heterogeneity at patient level (σ=1.37), provider level (τ=0.69) and site level (ψ ranges 
from 0.43 to 1.38).  
i
hλ
), which 
could be interpreted as site-level mean quality of ED outpatient pneumonia care. Sites with the 
high intensity intervention had significantly higher mean quality of outpatient care than sites 
with the low or moderate intervention (2.78 with 95% posterior intervals (1.21, 4.7) and 2.42 
with 95% posterior intervals (1.02, 4.1) respectively (Table 4-3). Latent means between 
moderate and low intensity intervention arms did not differ significantly. Furthermore, the factor 
loading parameters  in equation 4.6 also affect the estimation of the direct intervention effect. 
For comparison with the univariate analyses, global measures of the intervention effects in the 
scale of log odds ratio are calculated as iX γ λ (moderate vs. low: 0.18, high vs. low: 1.39 and 
high vs. moderate: 1.21), which differ somewhat from the average intervention effect on the 
individual outcomes in Table 4-2 (0.33, 1.27, 0.94, respectively) due to the different weight on 
each outcome. 
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Table 4-3 Posterior summaries for the latent variable model 
 Parameter Posterior summaries 
 Mean  Median sd 95% CI 
Baseline 
 (intercept) 
β 4.33 01 4.32 0.43 (3.53 , 5.23) 
β 1.09 02 1.08 0.37 (0.42 , 1.79) 
β -1.31 03 -1.32 0.43 (-2.13 , -0.52) 
β 2.57 04 2.58 0.27 (2.03 , 3.08) 
Discrimination 
parameters 
λ 0.20 1 0.16 0.16 (0.01 , 0.59) 
λ 0.79 2 0.76 0.19 (0.47 , 1.2) 
λ 0.87 3 0.85 0.24 (0.48 , 1.41) 
λ 0.25 4 0.23 0.14 (0.03 , 0.56) 
Stand deviation of random effect 
patient-level σ 1.37   1.37 0.12 (1.15 , 1.6) 
provider-level    τ 0.69 0.69 0.14 (0.4 , 0.95) 
Site-level outcome-specific 
ψ 1.38 1 1.33 0.44 (0.68 , 2.39) 
ψ 0.43 2 0.43 0.22 (0.06 , 0.89) 
ψ 0.68 3 0.69 0.25 (0.16 , 1.18) 
ψ 0.70 4 0.69 0.21 (0.32 , 1.14) 
Intervention    effect  
On 
 Latent mean 
γ 0.37 1 0.37 0.58 (-0.77 , 1.48) 
γ 2.78 2 2.72 0.91 (1.21 , 4.7) 
γ2-γ 2.42 1 2.36 0.79 (1.02 , 4.1) 
Global intervention effect on 
outcomes  
(Log odds ratio) 
1γ λ  
0.18 0.19 0.30 (-0.41 , 0.75) 
2γ λ  
1.39 1.39 0.34 (0.76 , 2.04) 
2 1( )γ γ λ−  1.21 1.20 0.30 (0.64 , 1.82) 
 
Figure 4-3 summarizes the estimated probabilities of receiving a process of care ( ijkhY ) as 
a function of latent trait ( iθ ) (equation 3.8). A steeper slope corresponds to higher ability of an 
outcome to differentiate between sites, and a stronger association with the latent trait. The 
relationship between the latent trait and outpatient performance outcomes are strongest for first 
dose of antibiotics in ED as well as treatment with compliant antibiotic therapy in ED, and 
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weakest for oxygen assessment.  This is not surprising, considering the contribution of the 
common variance to total variance of each outcome. First dose of antibiotics in emergency 
department is the largest contributor with 77% its total variance explained, followed by 
treatment with compliant antibiotic therapy in ED with 62%, compliant antibiotic therapy on 
discharge with 11% and oxygen assessment only 2% of the total variance. 
Table 4-4 displays the pairwise Spearman correlation coefficients between the site-level 
aggregated outcomes and the latent score ( iθ ). Timely first dose in the  
ED and treatment with compliant antibiotic therapy in the ED are highly correlated (r=0.75) with 
both the average score and the latent score (r ≥ 0.90 for each). Oxygen assessment is poorly 
correlated (r < 0.3) with the other variables.  
 
Figure 4-3 Estimated probability of receiving each performance measure as a function of the latent 
score 
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Table 4-4 Pairwise Spearman correlation coefficients for site-level aggregated outcomes and the estimated 
latent score 
Variable (1) (2) (3) (4) AVG LS 
(1) Oxygen assessment 1.00      
(2) First dose antibiotics 0.08 1.00     
(3) Compliant ED antibiotics -0.14 0.77 1.00    
(4) Complaint discharge antibiotics -0.15 0.32 0.44 1.00   
(AVG) Site-level average outcomes 0.05 0.90 0.93 0.52 1.00  
(LS) Latent score 0.06 0.92 0.90 0.37 0.96 1.00 
 
Figure 4-4 displays the scatter plot of latent score vs. site-level average outcomes by 
intervention arm. Higher levels of the intervention generally are associated with higher latent 
scores, except for a few poorly performing sites in the moderate intensity arm and two relatively 
well performing sites in the low intensity arm. 
Latent Score
-2
-1
0
1
2
3
4
Average Score
0.56 0.58 0.60 0.62 0.64 0.66 0.68 0.70 0.72 0.74 0.76 0.78 0.80 0.82 0.84 0.86 0.88 0.90 0.92 0.94
trt low Moderate High  
Figure 4-4 Scatter plot of site-level average outcomes and latent score for outpatient data 
 
Table 4-5 summarizes the posterior predictive checks of the fitted models, using the test 
statistics of site-level average outcomes by intervention arm. The first column T(y) lists the 
computed proportion from the observed data, and the next column T (yrep) shows the mean and 
95% C.I. of the computed proportion from the replicated data. The proposed model estimates 
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well the percentage of patients receiving each therapy by intervention arm. Most Bayesian p-
values are very close to 0.5, and none is close to 1 or 0, indicating no lack of fit of this model. 
Table 4-5 Summary of the posterior predictive checks for site-level aggregated outcomes by 
intervention arm 
Variable Low Intensity 
Intervention 
Moderate intensity 
Intervention 
High Intensity 
Intervention 
 T(y) 
% 
T(yrep
95% int. 
) P 
value 
T(y) 
% 
T(yrep
95% int. 
) P 
value 
T(y) 
% 
T(yrep
95% int. 
) P 
value 
Oxygen assessment 94.8 94.7 
(90.2, 98.3) 
0.56 95.6 95.6 
(93.2, 97.6) 
0.50 96.7 96.7 
(94.3, 98.7) 
0.51 
First dose 
antibiotics 
64.9 65.4 
(57.5, 73.6) 
0.57 70.1 70.0 
(65.5, 74.5) 
0.49 91.0 90.8 
(87.2, 94.0) 
0.47 
Compliant ED 
antibiotics 
29.3 28.8 
(21.3, 36.2) 
0.48 30.7 31 
(26.7, 35.5) 
0.57 65.6 65.5 
(60.3, 70.4) 
0.49 
Complaint 
discharge antibiotics 
80.5 82.8 
(75.9, 88.5) 
0.74 89.2 88.3 
(84.7, 91.8) 
0.32 90.7 90.7 
(87.4, 93.8) 
0.54 
 
4.6  SIMULATION STUDIES 
We conducted Monte Carlo simulation studies to check our algorithm and computational 
implementation of the proposed approach. All computations are performed by iteratively running 
WinBUGS interface inside SAS following the procedure proposed by Zhang (2008). Although 
WinBUGS is a convenient tool for estimating Bayesian models, it is not very flexible for 
simulation studies because it can run only a single model or a single data set at one time. 
However, SAS can be used to iteratively implement the simulation procedure.  
Data were simulated based on the model specified in equation (4.5). The “true” parameter 
values ranged around parameters estimates obtained from the analysis of outpatients data, to 
make the population models more realistic.  The level-1 unit covariate Xijk, is binary with p=0.5, 
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and level-4 unit covariate is a three-level categorical variable with p = (1/3,1/3,1/3).  The true 
values were set as: β0 = (4,1,-1.5,2.5), β1 
2 2 2/( )h h hλ λ ψ+
= (0.5, 0.2, 1.0, 0.2),  σ = 1.0, τ=0.6, ψ= (1.2, 0.5, 0.5, 
0.5), λ = (0.2, 0.6, 0.9, 0.3) and γ = (0.5, 2.5). As calculated by , the fractions of 
level-4 units variance explained by the common variance are 3%, 59%, 76% and 26% for the 
four items respectively, which is similar to the outpatient data. 
Simulation studies with two different sample sizes were considered, to investigate 
whether the sample size affected the parameter estimation. In simulation study 1, we generated 
30 hospitals with a total of 300 providers and 3000 patients. In simulation study 2, we double the 
sample size by generating 60 hospitals with a total of 600 providers and 6000 patients. The 
number of patients per provider varies with an average of 10 patients per provider. For each 
simulation, we generated 200 datasets. The true parameter values were based on parameter 
estimates obtained from the EDCAP data, to make the simulation models relevant to this study.  
With the prior distribution described in section 4.4.2, we first ran a few sets of data and 
found that the generated sequences for all parameters converged within 3000 iterations. 
Although we may use 3000 as the burn-in data, we used a burn-in period of 5000 iterations to 
ensure the convergence for all the other data sets, and then an additional 5000 observations were 
collected to produce the Bayesian estimates and their estimated standard errors.  Based on the 
200 replications, we computed the mean and the SD of the estimates of mean and median, the 
mean of the SD estimate (mean of SD), as well as the bias (which is the difference between the 
true parameter and the mean of the corresponding estimates), and the root mean squares (RMS) 
between the estimates and the true values.  
Table 4-6 summarizes the simulation results:  (i) As expected, increasing the sample size 
improves the accuracy of the estimates. (ii) The Bayesian estimates are reasonably accurate, with 
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bias for almost all parameters being less than 10% in n=3000 and less than 5% in n=6000. The 
exception was λ1, whose bias was 57% in the smaller sample and 25% in the larger sample. This 
is not surprising because only 3% total variance of the first outcome was explained by the latent 
trait. Also for this reason, the bias of the factor loading λ1 did not obviously affect the accuracy 
of the estimates (γ1, γ2 and γ2-γ1
1 1 1 2,   ( )andγ λ γ λ γ γ λ−
) of the intervention on the latent mean and global intervention 
( ). (iii) In most cases, the estimated SEs and SDs are close to each other; 
this indicates that the estimated SEs are consistent with the true SEs. (iv) In most cases, the 
estimates of mean or median are very close, but for the factor loading parameters (λ1, λ2, λ3, λ4) 
and the estimates of level-3 units fixed covariate effects (γ1, γ2 ), estimates of the median are 
closer to the true value with smaller bias in the smaller sample size. 
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Table 4-6 Posterior summaries for the parameters in the one-latent trait model from simulated data 
                                      N=3000                                   N=6000 
Parameter Bias of 
Mean 
SD of 
Mean 
Mean of 
SE 
RMS  Bias  of 
Median 
SD of 
median 
Bias of 
Mean 
SD of 
Mean 
Mean of 
SE 
RMS  Bias  of 
Median 
SD of 
median 
β0,1 -0.012 =4 0.322 0.374 0.321 -0.017 0.316 0.004 0.219 0.252 0.219 0.002 0.217 
β0,2 0.017 =1 0.259 0.265 0.259 0.018 0.26 0.017 0.178 0.18 0.179 0.02 0.178 
β0,3 0.005 =-1.5 0.39 0.358 0.39 0.007 0.393 0.015 0.277 0.241 0.276 0.017 0.279 
β0,4 0.005 =2.5 0.184 0.214 0.184 0.007 0.183 0.01 0.144 0.144 0.145 0.011 0.144 
σ=1.0 0.017 0.071 0.071 0.071 0.017 0.071 0.004 0.048 0.05 0.045 0.004 0.048 
ψ1 0.103 =1.2 0.297 0.301 0.315 0.067 0.287 0.051 0.188 0.19 0.195 0.036 0.186 
ψ2 -0.007 =0.5 0.124 0.159 0.122 -0.007 0.123 -0.012 0.099 0.108 0.1 -0.009 0.096 
ψ3 0.014 =0.5 0.179 0.227 0.179 0.012 0.19 -0.023 0.161 0.173 0.161 -0.017 0.171 
ψ4 0.004 =0.5 0.149 0.147 0.148 -0.004 0.146 0.01 0.093 0.095 0.095 0.006 0.091 
τ=0.6 0.003 0.062 0.058 0.063 0.002 0.062 0.007 0.042 0.04 0.045 0.007 0.042 
λ1 0.114 =0.2 0.169 0.193 0.202 0.083 0.168 0.05 0.111 0.13 0.122 0.037 0.114 
λ2 0.045 =0.6 0.163 0.157 0.167 0.032 0.161 0.02 0.104 0.1 0.105 0.014 0.103 
λ3 0.047 =0.9 0.194 0.21 0.2 0.033 0.191 0.021 0.137 0.136 0.138 0.017 0.136 
λ4 0.04 =0.3 0.125 0.123 0.13 0.029 0.125 0.01 0.083 0.08 0.084 0.006 0.082 
γ1 0.044 =0.5 0.612 0.574 0.612 0.027 0.591 -0.004 0.36 0.372 0.359 -0.008 0.357 
γ2 0.098 =2.5 1.011 0.868 1.014 -0.01 0.786 -0.015 0.537 0.513 0.536 -0.046 0.517 
γ2-γ1 0.055 =2.0 0.901 0.782 0.901 -0.032 0.689 -0.011 0.485 0.477 0.484 -0.034 0.468 
1γ λ =0.25 0.018 0.296 0.291 0.297 0.017 0.294 0.002 0.184 0.19 0.184 0 0.183 
2γ λ =1.25 0.057 0.264 0.312 0.268 0.048 0.263 0.006 0.218 0.209 0.217 0.001 0.218 
2 1( )γ γ λ− =1.0 0.038 0.291 0.312 0.293 0.03 0.29 0.004 0.202 0.206 0.202 0 0.202 
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4.7  DISCUSSION 
Multiple outcomes arise frequently in many fields of biomedical research. Existing commonly 
used standard software cannot analyze multiple outcomes from hierarchical data with more than 
two levels. We have described a flexible Bayesian latent variable model for the situation where 
several binary outcomes are measured to assess an intervention effect in a cluster-randomized 
clinical trial with 3-level hierarchical data. The difficulties induced by the complexities of the 
model and the multi-dimensional integrals are handled efficiently by the Gibbs sampler (Geman 
and Geman, 1984). Compared to traditional separate outcome analyses, this joint modeling 
approach provides a comprehensive way to analyze multivariate and hierarchical data, and leads 
to an intuitively appealing and useful interpretation of complex data.  In this proposed model 
framework, the intervention effect was assessed as one degree-of-freedom test, taking 
advantages of covariance between outcomes. The parameters of factor loading and outcome-
specific variance can be used to assess the relationship between outcomes, and identify those 
outcomes carry the most information about the latent trait. Another advantage of the latent 
variable model is that it naturally yields a summary measure for each site. As expected, our study 
shows that the latent scores were highly correlated with raw average outcomes (AVG, r=0.96). 
As Skrondal and Rabe-Hesketh (2004) pointed out, sometimes an extremely simple approach 
appears to work as well as much more cumbersome methodologies. However, the raw average 
methodology cannot be directly applied to clusters with missing data, and cannot incorporate 
covariance information or relationships between latent variables, in contrast to model based 
approach.  
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Methods proposed here easily should be extendable to any distributions from exponential 
family. For multilevel data, the model could be generalized to allow additional covariates at 
different hierarchical levels. Covariates can be added to the within-site model (4.1), between-site 
model (4.2), or on the latent variable level θ i 
In this paper, it has been assumed that the outcomes are conditionally independent given 
the common latent construct. This bears a close similarity to random-effects models, where, 
given the random effect, outcomes are assumed to be independent. We will consider extending 
the model to relax this local independence assumption and allow conditional dependence 
between outcomes in future work. Another important assumption is that we assume the 
directions of intervention effects are consistent across outcomes when specifying the prior 
distribution for factor loadings {λ
(4.3) as appropriate. For cross-sectional data 
without a hierarchical structure, the model can be framed differently by combining the within 
site and between site models. 
h
 
}, as truncated normal distributions above 0 for model 
identification. This assumption seems reasonable in our EDCAP outpatient data because 
individual outcome analyses showed the positive intervention effects across all outcomes 
regardless of significance (Table 4-2).  While we considered in this paper the situation where the 
multiple outcomes are binary, different outcome types, including both continuous and discrete 
endpoints, can be incorporated into the proposed model framework. Finally, in clinical trials, it 
might be interesting to examine whether interventions influence the degree of heterogeneity 
(variation) across health care providers. The estimated variance components would be of great 
interest, and potentially could be jointly modeled with the regression coefficients.  
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5.0  TWO-LATENT VARIABLE MODELS FOR ESTIMATING AN INTERVENTION 
EFFECT FROM MULTIDIMENSIONAL HIERARCHICAL DATA 
5.1 ABSTRACT  
Multiple outcomes are collected commonly in clinical trials. In this article, we propose fully 
Bayesian latent variable approaches, including one and two latent variable models, to estimate an 
overall intervention effect for the situation where multiple outcomes are obtained from 
hierarchical data. This approach incorporates the correlation structure into one or more latent 
outcomes, and simultaneously regresses the latent outcome(s) on the intervention. Random 
effects are included to model the hierarchical structure. This method is applied to data from a 
cluster-randomized clinical trial with multiple binary outcomes and a 3-level hierarchical 
structure. Not only does the method allow assessment of intervention effects with respect to 
multiple outcomes, but it also assesses the relationship between outcomes, identifies those 
outcomes that carry the most information about the latent trait, and provides a measure of the 
“quality of care” of each clinical site. 
Key Words: hierarchical models, Bayesian approach, multiple latent traits  
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5.2 INTRODUCTION 
Statistical issues that arise when evaluating an intervention effect from multi-center clinical trials 
with multiple endpoints include multidimensionality (because each response variable measures a 
slightly different aspect of the effect of interest), autocorrelation between observations within the 
same site, and cross-correlation between different response variables both across and within 
sites. Often, a unidimensional composite score is of interest, such as an overall measure of 
quality of care in health care research (Teixeira-Pinto and Normand 2008).  
Commonly used approaches such as dimension reduction and global test procedures fail 
to characterize relationships between outcomes or summarize their individual effects. Latent 
variable models (i.e., models that include random unobserved variables) provide a natural way to 
analyze such complex multivariate data when an underlying hypothetical construct is assumed 
(Skrondal and Rabe-Hesketh, 2004). Following the very general model framework of 
generalized linear latent and mixed models (GLLAMMs) (Skrondal & Rabe-Hesketh, 2004 and 
2007), latent variable models can be formalized by writing two submodels: a response model and 
a structural model. The response model specifies the distribution of the observed responses 
conditional on the latent variables and covariates, which extends generalized linear mixed 
models (GLMMs) to incorporate factor structure in addition to random intercepts and 
coefficients; in the structural model, the latent variables themselves may be regressed on other 
latent and observed covariates.  
One advantage of the latent variable model is that a one degree-of-freedom likelihood 
ratio test of the overall covariate effect can be more powerful than a M degree-of-freedom test 
(Sammel, 1999). Another advantage is that a summary latent score for each individual can be 
estimated (Legler and Ryan, 1997).  These latent variable models have been employed 
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extensively in psychological and educational testing (Baker, 1992) and the social sciences (Eye 
and Clogg, 1994), and in recent years, use has been increasing in medical and public health 
research (Legler and Ryan, 1997; Sammel, et al., 1997; Donaldson, 2003; Teixeira-Pinto and 
Normand, 2008). Much of the literature on latent variable models is from a frequentist 
perspective, based on maximum likelihood estimation. Computation is intensive and difficult, 
because in general no closed form exists for the multi-dimensional integrals. Bayesian 
alternatives using Markov Chain Monte Carlo (MCMC) are becoming more popular and 
attractive because of their flexibility (Lee and Song, 2003 and 2004; Dunson et al., 2003). The 
difficulties induced by the complexities of the multi-dimensional integrals can be handled 
efficiently by powerful computing tools, such as the Gibbs sampler (Sik-Yum Lee, 2007).  
In this chapter, we implement Bayesian estimation of multilevel latent variable model to 
asses an overall intervention effect on multiple binary outcomes from a 3-level cluster-
randomized clinical trial. In Section 5.3, we present the motivating example of the Emergency 
Department Community Acquired Pneumonia (EDCAP) study (Yealy et al., 2004), In Section 
5.4, we describe our one- and two-latent trait models for clustered binary outcomes, and 
implement Bayesian estimation in WinBUGS 1.4 (Windows version of Bayesian inference Using 
Gibbs Sampling, Gilks, 1994). We illustrate the proposed methodology using the EDCAP data in 
section 5.5, and conclude with a discussion in section 5.6.  
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5.3  THE EDCAP EXAMPLE 
Data from the cluster-randomized EDCAP trial motivated this proposed method. The EDCAP 
study was designed to compare the effectiveness and safety of three guideline implementation 
strategies of increasing intensity (low-intensity, moderate-intensity, and high-intensity) on 
quality of care of Community Acquired Pneumonia (CAP) in Emergency Departments (EDs) 
(Yealy et al., 2004). The study guideline recommended outpatient care for low risk patients with 
CAP who presented to the ED, and inpatient care for high risk patients. Four processes of care 
were recommended for outpatient care and inpatient care respectively, including oxygen 
assessment, first dose of antibiotics in ED, treatment with compliant antibiotics in the ED, and 
compliant antibiotic therapy upon discharge for outpatients; oxygen assessment, blood cultures 
before antibiotic administration, antibiotic administration within 4 hours and treatment with 
compliant antibiotic therapy in the ED for inpatients. So, there are eight processes of care 
outcomes considered here. 
The EDCAP data have a 3-level hierarchical data structure, in which multiple outcomes 
are nested within patients, patients are nested within providers, and providers are nested within 
clinical sites (EDs).  The three intervention arms were randomized at the site level. The 3201 
patients were seen by 407 providers at 32 clinical sites; 1125 patients were assigned to outpatient 
care and 2076 were assigned to inpatient care.  Each patient had four binary outcomes from 
either inpatient care or outpatient care, with 1 indicating that the patient received the 
recommended process of care, 0 otherwise. Site-level average proportions of patients receiving 
recommended processes of care are summarized in Table 5-1. Scatter plots of the site-level 
average outcomes (proportions of patients receiving recommended processes of care) by 
intervention arm are graphed in Figure 5-1. In general, sites with higher intensity interventions 
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had higher proportions of patients receiving the recommended processes of care, with the 
exceptions of outpatient and inpatient oxygen assessment and antibiotics within in 4 hours for 
inpatients. Oxygen assessment had a ceiling effect, with little variability across sites.  
Table 5-1 Site-level average proportions of patients receiving recommended processes of care 
Processes of care 
Low 
intensity 
intervention 
% 
Moderate 
intensity 
intervention 
% 
High 
intensity 
intervention 
% 
Outpatient processes N=174 N=498 N=453 
Oxygen assessment 95.7 (4.1) 94.6 ( 7.5) 96.9 ( 3.4) 
First dose antibiotics in ED 64.8 ( 9.4) 70.8 (18.2) 90.6 ( 5.7) 
Compliant ED antibiotics 29.0 (13.4) 35.4 (23.1) 63.7 (15.4) 
Complaint discharge antibiotics 79.1 ( 8.9) 90.0 ( 5.0) 89.4 ( 8.1) 
Inpatient processes N=566 N=661 N=849 
Oxygen assessment 97.4 ( 2.9) 99.2 ( 1.4) 97.7 ( 3.2) 
Blood cultures before antibiotics 55.8 (17.6) 58.3 (13.0) 74.0 ( 9.1) 
Antibiotics within 4  h 78.9 (14.6) 80.8 ( 9.2) 77.8 ( 8.2) 
Compliant antibiotics in ED 44.9 (14.2) 59.2 (19.3) 71.2 (14.0) 
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Figure 5-1 Site-level average outcomes (i.e., proportions of patients receiving each recommended 
process of care) by intervention arm 
  
Estimated intervention effects from analyses of individual outcome are summarized in 
Table 5-2. We ran separate random effect logistic regression models to estimate the log odds of a 
patient receiving each recommended process of care as a function of intervention arm, adjusting 
for patient risk status (low risk vs. high risk) and accounting for clustering at both the provider 
level and the site level.  Models were fitted using GLAMM in Stata 10. In total, 24 pairwise 
comparisons were conducted for the 8 individual outcomes across 3 intervention arms. Type I 
error is increased with all of these univariate analyses. Only the intervention effects on outpatient 
outcomes of the first dose of antibiotics and compliant antibiotic therapy in the ED, and inpatient 
outcomes of blood culture before antibiotics and compliant antibiotics in ED reached statistical 
significance once the multiple testing was taken into account using a Bonferroni correction 
Oxygen assessment                             First dose of antibiotics  
in ED      
Treatment with compliant 
antibiotics therapy in ED 
Compliant antibiotic 
therapy on discharge 
Oxygen assessment                             Blood cultures before 
antibiotic administration   
Antibiotic administration 
within 4 h 
Treatment with compliant  
antibiotic therapy in ED 
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(Miller, 1981). An overall intervention effect cannot be estimated from those individual data 
analyses. 
Table 5-2 Estimated intervention effects from univariate random effect logistic regression models 
Variable 
Moderate vs. low 
intensity 
intervention 
Log OR (95% CI) 
High vs. low 
intensity 
intervention 
Log OR (95% CI) 
High vs. moderate 
intensity 
intervention 
Log OR (95% CI)  
Overall  
P value 
 
 Outpatient processes of care     
Oxygen assessment 0.10 (-1.09, 1.29) 0.40  (-0.82, .63) 0.30  (-0.73, 1.34) 0.78 
First dose antibiotics in ED 0.26  (-0.50, 1.01) 1.90 (1.08, 2.72) 1.65  (0.92, 2.37) <0.001 
Compliant ED antibiotics 0.19 (-0.66, 1.04) 1.78 (0.93, 2.64) 1.59 (0.86, 2.33) <0.001 
Complaint discharge antibiotics 0.77 (0.08, 1.47) 0.99 (0.28, 1.70) 0.22  (-0.41, 0.85) 0.02 
Inpatient processes of care     
Oxygen assessment 1.34 (-0.04, 2.73) 2.15 (-0.97, 1.40) -1.13 (-2.43, 0.17) 0.13 
Blood cultures before antibiotics  0.18 (-0.36, 0.72) 0.94 (0.40, 1.48) 0.76 (0.27, 1.25) <0.001 
Antibiotics within 4  h 0.11 (-0.47, 0.68) -0.11 (-0.68, 0.46) -0.22 (-0.73, 0.30) 0.79 
Compliant antibiotics in ED 0.62 (-0.04, 1.29) 1.27 (0.61, 1.93) 0.65 (0.05, 1.24) <0.001 
5.4  LATENT VARIABLE MODELS 
We describe our method in the context of EDCAP example. First we analyze the data separately 
for outpatients and inpatients using one-latent trait models, and then we combine the two sets of 
data in one model framework using a two-latent trait model to assess the relationship between 
the two latent traits. 
Because of the unobserved structural relationships among outcomes at patient level (e.g., 
outcomes of outpatient care are measured only on outpatients and outcomes of inpatient care are 
measured only on inpatients), let Yijkh,out = (yijk1, yijk2, yijk3, yijk4) denote a vector of outpatient 
outcomes  and Yijkh,in = (yijk5, yijk6, yijk7, yijk8) denote a vector of inpatient outcomes.  Each yijkh 
denotes the hth response (ordered as in Table 1) of the kth (k = 1,2,…nij) patient treated by 
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provider j (j = 1,2,…ni) in site i (i = 1,2…32). Let Xi {(xi1, xi2), where (0, 0) = low intensity, (1, 
0) = moderate intensity, (1, 1) = high intensity intervention)} denote the site-level intervention 
arms, and Zijk
5.4.1 One latent trait model 
 (0 = low risk, 1 = high risk) be the covariate denoting patient-level risk status. 
Please note that each patient only has four outcomes from either outpatient care or inpatient care, 
due to the structural missing data. 
The one latent trait model is illustrated using four outcome measures. Because EDCAP is a 
cluster randomized clinical trial and the intervention effect is assessed at site level, in the 
proposed model framework the latent variable is defined at the site level rather than the patient 
level. 
Response Model. The response model regresses the outcomes with a small number of latent 
variables adjusting for covariates and accounting for the clustering. Each outcome is assumed to 
follow a binomial distribution and is linked by logit link to a site-level latent trait, a patient-level 
covariate, a patient-level random effect, a provider-level random effect, and a site-level outcome-
specific random effect: 
0h 1h 0h 1h ijk ij ijk( | , , , , , , ) + z + + +ijkh h i ijk ij ih ijk h i ihLogit y zβ β λ θ µ υ ε β β λ θ ε υ µ= +   
In matrix form 
[ ]
1 01 111 1
2 02 212
3133 03 3
41404 44
log ( )
log ( ) 1
log ( )
log ( )
ijk i
ijk i
ijk i ij ijk
ijk i
iijk
it y
it y
Z
it y
it y
β εβ λ
β εβ
θ ν µ
λββ ε
λββ ε
        
        
        = + + + + +        
        
             
   
(5.1) 
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In (5.1), the β0h denote a baseline for each outcome, indicating performance of the hth 
process of care at an average site with the low-intensity intervention for low risk patients. The 
β1h denote fixed outcome-specific regression coefficients for the patient-level covariate of risk 
status (Zijk h iλ θ). The term  models the correlation between the outcomes at the site-level, such 
that the site-level outcomes are conditionally independent given the latent variable θ i. In this 
example, the underlying site-level latent variable θ i can be considered as a hypothetical construct 
of “quality of outpatient (or inpatient) pneumonia care in ED” rendered by site i, with larger 
values denoting better quality of care, and λh is fixed outcome-specific discrimination parameter 
(weight), which quantifies the weight of each outcome on the latent variables and indicates the 
ability of each outcome to discriminate between sites. Larger values for λh correspond to 
outcomes that better discriminate the underlying quality of care. The model identification is 
achieved by anchoring, where we set λ2
2
ijk ~N(0, )µ σ
=1 to fix the scale of the latent variable. We model the 
correlation between the four outcomes within patient by a patient-level random 
effect , the correlation between patients within providers by a provider-level 
random effect 2ij ~ (0, )Nυ τ , and a site-level outcome-specific random effect εih ~ (0, ψh
2) that 
permits heterogeneity across sites. The random effects µ ijk, νij, and εih are assumed 
Structural Model. The structural model regresses the latent variables on the observed 
covariate of intervention (X
to be 
mutually independent.  
i), such that variability in latent quality (θi
                                    
) across sites has both a 
systematic component, explained by the site-level interventions, and a random component:  
2
2
 where ~ (0, ),   i.i.d error term
. . ~ ( , )
i i i i
i i
X N an
i e N X
θ γ α α φ
θ γ φ
= +
  (5.2) 
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In (5.2), γ (γ1 , γ2 ) is the vector of fixed treatment effects on the site-level latent trait (θ), 
with γ1 denoting a contrast between the moderate intensity vs. low intensity intervention, and γ2
Combining equations 5.1 and 5.2, the full model can be formulated in one equation:       
 
denoting a contrast between the high intensity vs. low intensity intervention, respectively. 
0h 1h 0h 1h ijk ijk ij
22 2 2
ijk ij
( | , , , , , , , , ) + z + + +
   ~N(0, ), ~ (0, ), ~N(0, ), and ~ (0, )
ijkh h ijk ij ih ijk i h i h i ih
i ih h
Logit y z X X
where N N
β β λ γ µ υ ε β β λ γ λ α µ υ ε
µ σ υ τ α φ ε ψ
= + +
 
 Bayesian estimation of latent variable models treat latent quantities ( )Ω , including the 
latent trait and random effects, as hypothetical missing data. For the proposed model, the 
augmented complete data likelihood function takes the form: 
32 4
0 1 0h 1h
1 1 1 1
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1 1 1
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A total of 20 unknown parameters appear in the full model for four outcomes from 3-
level hierarchical data. We also fit reduced models by removing those outcomes that were poorly 
correlated with other measures or affected by intervention in a different manner, to see if model 
fit improved. We fitted a reduced model of outpatient data by imposing λ1=0, since oxygen 
assessment (outcome 1) has a ceiling effect and little variation. We fit a reduced model for 
inpatient data by imposing λ1=0 and λ3=0 for the outcomes of oxygen assessment (due to the 
(5.3) 
 
(5.4) 
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ceiling effect) and antibiotics within 4 hours because it was not affected by the intervention in 
the same manner as the other processes of care for inpatients (See Figure 5-1, Table 5-1, Table 5-
2).   
Path diagrams summarize these full latent trait and reduced models (Figure 5-2).  Here 
circles represent the latent variables, rectangles represent the observed data, free-standing letters 
represent parameters, arrows connecting circles and/or rectangles represent linear/non linear 
relationships, and short arrows pointing at circles or rectangles represent residual variability. 
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Figure 5-2 Path diagram of one latent trait models. A: full model, B: reduced model for outpatient 
data, C: reduced model for inpatient data 
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5.4.2 Two latent trait model 
Instead of modeling outpatient outcomes and inpatient outcomes by two separate one latent 
variable models, here we model all the outcomes in one model framework using a two latent trait 
model, with one trait representing quality of outpatient care and the other one representing 
quality of inpatient care. The covariance structure of the two traits also can be assessed. 
Response Model. Model specification is same as (3.1), but with separate equations for 
outpatient care and inpatient care (due to the structural missing of outcomes at the patient level). 
Let ,i outθ and ,i inθ denote the outpatient and inpatient latent traits, respectively. Based on the 
preliminary results from the one latent trait models, different patient level random effects and the 
same provider effect were specified for the following two equations. 
, 0h 1h , , 0h 1h ijk , ijk,out ij( | , , , , , , , ) + z + + +ijkh out h i out ijk out ij ih ijk h i out ihLogit y zβ β λ θ µ υ ε β β λ θ µ υ ε= +               
, 0h 1h , , 0h 1h ijk , ijk,in ij( | , , , , , , , ) + z + + +ijkh in h i in ijk in ij ih ijk h i in ihLogit y zβ β λ θ µ υ ε β β λ θ µ υ ε= +  
We combine the two equations in above by defining an indicator variable of outp with 1 
indicating that the patient was assigned to outpatient care and 0 indicating that the patient was 
assigned to inpatient care. 
             0h 1h , , , ,
outp 1-outp outp 1-outp
0h 1h ijk , , , , ij
( | , , , , , , , , , )
                 + z +( ) ( ) +( ) ( ) +
ijkh h i out i in ijk out ijk in ij ih ijk
h i out h i in ijk out ijk in ih
Logit y zβ β λ θ θ µ µ υ ε
β β λ θ λ θ µ µ υ ε= +
 
In (3.5), 2ijk,out ~N(0, )outµ σ  and
2
ijk,in ~N(0, )inµ σ  denote outpatient and inpatient patient-
level random effects respectively, 2ij ~ (0, )Nυ τ denotes provider-level random effects, and εih ~ 
(5.5) 
 
(5.6) 
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(0, ψh2
Structural Model. The outpatient and inpatient latent traits are regressed on the 
intervention separately, and estimates of the intervention effects are allowed to differ across the 
two traits.  
) denotes site-level outcome-specific random effects. The model identification is achieved 
by anchoring, where we fix the scale of each trait by setting one factor loading to 1. 
, ,( , ) ~ ( ` ,  )i i out i in T iN X Rθ θ θ= Σ  
where 1, 2,
1, 2,
 
  
out out
in in
r r
R
r r
 
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 
 is a 2 X 2 vector representing outpatient and inpatient 
intervention effects of moderate intensity vs. low-intensity and high-intensity vs. low-intensity 
intervention, respectively, and 11 12
21 22
 
 
φ φ
φ φ
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 denotes a covariance matrix of the two latent 
variables. The augmented complete data likelihood function takes the form: 
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Preliminary results of the one latent trait models showed that the outpatient latent trait 
was constructed mainly by three outcomes (first dose of antibiotics in ED, compliant ED 
antibiotics and complaint discharge antibiotics), and the inpatient latent trait was constructed 
mainly by two outcomes (Blood cultures before antibiotics and Compliant antibiotics in ED). 
These five outcomes are used to fit the two-latent trait model. Though two separate latent traits 
were modeled, this integrated model will allow exploration of the relationship between the two 
latent traits. In the path diagram shown in Figure 5-3, 12φ  denotes the correlation between the 
latent traits for outpatient and inpatient care conditional on intervention effects. 
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Figure 5-3 Path diagram of the two latent traits model 
 76 
5.4.3 Model estimation 
Bayesian estimation of the model parameters requires the specification of a prior distribution for 
each unknown parameter. For the fixed effects ({β0h}, {β1h}, {γ}) and factor loadings {λh}, we 
use diffuse priors N (0, 104), independent normal distributions with mean zero and large 
variance, respectively. For the variance parameters (σ, τ, {ψh φ} and ), we used uniform (0,100) 
as priors (Gelman 2006). In the two latent traits model, a Wishart (R, r) prior was specified for 
the covariance matrix Ω. To represent non-informative prior, we chose a large degree of freedom 
as r=8. The scale matrix was specified as 
1 0
0 1
R  =  
 
(Lee and Song 2003). We assume that the 
prior distributions of each these parameters are independent. The generic Bayesian Package 
WinBUGS1.4 (Spiegelhalter, Thomas, Best and Lunn, 2003) was used to simulate the posterior 
distribution using MCMC. For our model, we used double chains with two sets of varied initial 
values. The convergence of the MCMC sampler was assessed by examining trace plots.  The 
deviance information criterion (DIC) (Spiegelhalter et al., 2002) was computed as an overall 
measure of relative model fit to compare full and reduced models, with smaller DIC being better.  
 The Bayesian estimates of posterior means and 95% credible intervals are summarized 
for the final models. Estimates of the site specific latent scores (i.e., value of latent variable at 
each site) are given by the posterior mean of θ i. To visualize the association between each 
outcome and the latent trait ((θi
ijkhY
), we plot the estimated probability of receiving a process of care 
( ) as a function of the latent trait ( iθ ). Of the parameters charactering these curves, β0h 
quantifies the intercept, and λ  h quantifies the steepness of the curve.   
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We also estimated the relative contribution of the common variance to the total variance 
of each outcome as 
                                               
2 2 22 2/( )h h hλ φ λ φ ψ+         
IN (5.10), hλ  is the outcome-specific factor loading, and 
2
hψ  is the site-level outcome specific 
variance. Scatter plots of the outpatient latent score vs. inpatient latent score from the two-latent 
trait model are shown by intervention arm. 
5.5 APPLICATION TO THE EDCAP DATA 
We applied the proposed approaches to the EDCAP data, to assess whether site-level quality of 
pneumonia care varied systematically by intervention arm. One latent trait models were fit first 
for outpatient data and inpatient data separately, and then the two latent trait model was fit to 
model inpatient and outpatient care simultaneously. Our parameter estimates were based on the 
output of a Gibbs sampler of 10,000 iterations after eliminating the first burn-in of 10000 
iterations (double chains). All the results are based on the pooled two chains, that is, a sample 
size of 20,000 deviates. 
5.5.1  One latent trait model results 
Compared to the respective full models (Figure 5-2a), both the outpatient reduced model with 
oxygen assessment removed from the latent trait (Figure 5-2b) and inpatient reduced model with 
(5.9) 
(5.10) 
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oxygen assessment and antibiotics within 4 hours (Figure 5-2c) had almost the same DIC 
(Outpatient full model vs. reduced model: 3207, 3208; Inpatient full model vs. reduced model: 
7524, 7523). Given the tiny differences in DIC values between the full model and reduced 
model, we choose to present here the results from the full model. Results of the reduced models 
are not shown, but the corresponding estimates of the parameters are very similar to the full 
models shown here. 
Posterior summaries of selected parameters characterizing the hierarchical structure and 
relationships between intervention and outcomes of the full models are shown in Table 5-3. The 
larger the intercept (β0h), the higher the proportion of patients received the therapy on average. 
Oxygen assessment has best average performance, which is in agreement with ceiling effect seen 
in Figure 1, and treatment with compliant antibiotic therapy in outpatient care had the poorest 
average performance. Two outcomes of outpatient care (first dose of antibiotics in ED and 
treatment with compliant antibiotic therapy in ED) and two outcomes of inpatient care (blood 
culture before antibiotics and treatment with compliant antibiotic therapy in ED) had relatively 
larger values of the discrimination parameter (λh
The intervention effect was modeled on the site-level latent trait (θ
); larger weight on the latent traits indicates that 
those therapies had larger variability across sites and potentially more discriminatory power for 
site performance. The data show obvious heterogeneity at patient-level (σ = 1.36 and 0.50 for 
outpatients and inpatients, respectively), provider-level (τ=0.70 and 0.43) and site-level (ψ 
ranges from 0.48 to 1.43).  
i), which could be 
interpreted as a site-level mean quality of ED outpatient (or inpatient) pneumonia care. Sites with 
the high intensity intervention had significantly higher mean quality of outpatient and inpatient 
care than sites with the low or moderate intensity interventions (outpatient: estimate of mean 
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differences of high vs. low = 1.98, 95% posterior interval = (0.98, 3.06) and high vs. moderate = 
1.73, 95% posterior interval = (0.85, 2.63) respectively; inpatient: high vs. low = 0.72, 95% 
posterior interval = (0.14, 1.33) and high vs. moderate = 0.50, 95% posterior interval = (0.06, 
1.1) respectively, Table 5-3). Latent means between moderate and low intensity intervention 
arms did not differ significantly.  
To estimate the direct overall intervention effect, we must recall that the factor loading 
parameters hλ  in equation 3.3 also affect the estimation of the direct intervention effect. Hence, 
global measures of the intervention effects in the scale of log odds ratio are calculated as 
iX γ λ (Outpatient: 0.16, 1.21 and 1.06 for moderate vs. low, high vs. low and high vs. moderate 
respectively; inpatient: 0.14, 0.36 and 0.23 respectively ). None of the global intervention effects 
is significant for inpatient data, because the two outcomes of oxygen assessment and antibiotics 
within 4 hours are negatively associated with the intervention by negative factor loadings (-0.48, 
-0.28 respectively), which is in agreement with the individual outcome analyses in Table 5-2. 
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Table 5-3 Posterior summaries for one latent variable models of outpatient and inpatient data 
  Outpatient model Inpatient model 
 Parameter Mean  95% CI Mean  95% CI 
Baseline 
 (intercept) 
β 4.58 01 (3.64,5.73) 4.42 (3.3 , 5.72) 
β 1.13 02 (0.34,1.89) 0.16 (-0.25 , 0.59) 
β -1.30 03 (-2.26,-0.47) 1.41 (1 , 1.87) 
β 2.59 04 (2,3.11) -0.10 (-0.65 , 0.45) 
Discrimination 
parameters 
λ 0.00 1 (-0.7,0.64) -0.48 (-4.75 , 2.79) 
λ 1.00* 2 NA 1.00* NA 
λ 1.18 3 (0.76,1.75) -0.28 (-2.04 , 0.84) 
λ 0.31 4 (-0.04,0.69) 1.99 (0.43 , 6.41) 
Stand deviation of random effect 
patient-level σ 1.36   (1.13,1.6) 0.50 (0.32 , 0.66) 
provider-level    τ 0.70 (0.46,0.97) 0.43 (0.32 , 0.53) 
Site level outcome-
specific 
ψ 1.40 1 (0.64,2.45) 1.43 (0.7 , 2.54) 
ψ 0.48 2 (0.08,0.92) 0.58 (0.35 , 0.85) 
ψ 0.63 3 (0.1,1.16) 0.60 (0.39 , 0.87) 
ψ 0.70 4 (0.29,1.16) 0.72 (0.32 , 1.05) 
Stand deviation of latent 
trait 
φ  0.75 (0.39,1.16) 0.14 (0.01 , 0.42) 
Intervention    effect 
on latent mean 
γ 0.25 1 (-0.61,1.19) 0.22 (-0.2 , 0.65) 
γ 1.98 2 (0.98,3.06) 0.72 (0.14 , 1.33) 
γ2-γ 1.73 1 (0.85,2.63) 0.50 (0.06 , 1.1) 
Global intervention 
effect  
(Log odds ratio) 
1γ λ  
0.16 (-0.39,0.76) 0.14 (-0.06 , 0.53) 
2γ λ  
1.21 (0.56,1.99) 0.36 (-0.13 , 0.95) 
2 1( )γ γ λ−
 
1.06 (0.49,1.7) 0.23 (-0.13 , 0.61) 
 
Figure 5-4 displays the estimated probability of receiving a recommended process of care 
( ijkhY ) as a function of latent trait ( iθ ) (equation 5.7). A steeper slope corresponds to higher 
ability of an outcome to differentiate between sites, and a stronger association with the latent 
trait. The relationship between the latent trait and outpatient performance outcomes are strongest 
for first dose of antibiotics in ED as well as treatment with compliant antibiotic therapy in ED, 
*fixed values for model identification 
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and weakest for oxygen assessment. The relationship between the latent trait and inpatient 
performance outcomes are strongest for blood culture before antibiotics as well as treatment with 
compliant antibiotic therapy on discharge, and weakest for the other two outcomes, even 
negatively associated with antibiotics within in 4 hours. This result is not surprising, as looking 
at the contribution of the common variance to total variance of each outcome calculated by 
equation (5.10). The values are 0%, 71%, 66% and 10% for the four outpatient outcomes, 
respectively, and 0.2%, 6%, 0.4% and 13% for the four inpatient outcomes respectively 
(outcomes are ordered as in Table 5-1,.  
 
Figure 5-4 Estimated probability of receiving each performance measure as a function of the latent 
score for outpatients and inpatients 
 82 
5.5.2  Two latent trait model results 
Posterior summaries of selected parameters in the two latent trait model characterizing the latent 
traits and intervention effects are shown in Table 5-4. The point estimates of discrimination 
parameters and intervention effects for the outpatient outcomes are very close to the results from 
the one-latent trait model, but with a stronger intervention effect. The global intervention effect 
in inpatient care turned to be significant because the two outcomes, oxygen assessment that was 
not associated and antibiotics within 4 hours that was negatively associated with the 
interventions were removed from the analysis, otherwise, the global intervention effect will be 
cancelled out. This is analogous to interaction data analysis, i.e., if the intervention effect 
significantly varies across outcomes, it is not appropriate to estimate overall single intervention 
effect on all outcomes. As in the single latent trait models, no intervention effect was observed 
for the moderate intensity versus low intensity comparison. The intervention effects were 
stronger in outpatient care than inpatient care. The outpatient latent trait had higher variation 
than inpatient latent trait (variance of 0.24 vs. 0.11), and the two traits are uncorrelated after 
accounting for the intervention effect (r = 0.06, 95% posterior interval: -0.53, 0.61).  
Figure 5-5 displays the scatter plot of estimated outpatient latent score vs. inpatient latent 
score by intervention arm. For both traits, higher levels of the intervention generally are 
associated with higher latent scores, except for a few poorly performing sites in the moderate 
intensity arm. Overall, the two traits are positively correlated, but within in each intervention 
arm, there seems to be no correlation, i.e., the two latent traits do not exhibit site-level clustering 
after adjusting for intervention arm. 
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Table 5-4 Posterior summaries of the two latent trait model 
 Parameter Posterior summaries 
 Mean Median sd 95% CI 
Discrimination 
parameters 
λ 1.13 13 1.11 0.27 (0.67 , 1.71) 
λ 0.33 14 0.32 0.20 (-0.03 , 0.74) 
λ 0.92 28 0.90 0.37 (0.26 , 1.71) 
Intervention    effect on 
latent mean, outpatient 
γ 0.40 1 0.38 0.45 (-0.44 , 1.31) 
γ 2.37 2 2.35 0.53 (1.36 , 3.47) 
γ2-γ 1.97 1 1.96 0.43 (1.15 , 2.83) 
Global intervention effect 
on outcomes, outpatient 
1γ λ  
0.32 0.31 0.36 (-0.36 , 1.08) 
2γ λ  
1.92 1.91 0.40 (1.18 , 2.73) 
2 1( )γ γ λ−  1.59 1.59 0.32 (0.98 , 2.23) 
Intervention    effect on 
latent mean, inpatient 
γ 0.25 1 0.24 0.25 (-0.22 , 0.76) 
γ 0.98 2 0.97 0.27 (0.49 , 1.55) 
γ2-γ 0.74 1 0.73 0.27 (0.22 , 1.29) 
Global intervention effect 
on outcomes,  inpatient 
1γ λ  
0.24 0.23 0.23 (-0.19 , 0.72) 
2γ λ  
0.93 0.93 0.25 (0.44 , 1.45) 
2 1( )γ γ λ−  0.69 0.69 0.25 (0.21 , 1.19) 
Covariance between  latent 
traits 
Ф 0.24 11 0.21 0.14 (0.07 , 0.6) 
Ф 0.11 22 0.10 0.05 (0.05 , 0.23) 
Ф 0.01 12 0.01 0.06 (-0.1 , 0.14) 
corr 0.06 0.07 0.30 (-0.53 , 0.61) 
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Figure 5-5 Scatter plot of outpatient latent scores versus inpatient latent scores 
5.6  DISCUSSION 
We have described a flexible Bayesian latent variable model for the situation where several 
binary outcomes are measured to assess an intervention effect in a cluster-randomized clinical 
trial with 3-level hierarchical data. The method not only allows assessment of intervention 
effects with respect to multiple outcomes, but also assesses the relationship between outcomes, 
identifies those outcomes that carry the most information about the latent trait(s), allows for 
structural missingness, and provides a summary measure of the “quality of care” at each clinical 
site across patient subgroups. In the EDCAP study, this approach showed that latent scores for 
the quality of both outpatient and inpatient care were highest for the high intensity intervention 
sites, and that these traits were essentially uncorrelated.  
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Methods proposed here are extendable to any distributions of exponential family. For 
multilevel data, the model can be generalized to allow additional covariates at either response 
model (first stage) or structural model (second stage), as appropriate. In EDCAP study, the 
intervention was added at the second stage because the intervention was randomized at the site 
level.  
One important assumption is that the outcomes are conditionally independent given the 
common latent construct. This bears a close similarity to random-effects models, where 
outcomes are assumed to be independent given the random effects. We will consider extending 
the model to relax this local independence assumption to allow conditional dependence between 
outcomes in future work.  While we considered multiple binary outcomes in this paper, different 
outcome types can be incorporated into the proposed model framework, including both 
continuous and discrete endpoints.  
In summary, this latent variable approach provides a comprehensive alternative to 
traditional individual outcome analysis to quantify intervention (or exposure) effects with regard 
to multiple outcomes in hierarchical data setting. The two latent trait model allows a joint 
assessment of quality of care for two distinct subgroups of patents. 
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6.0  CONCLUSION AND DISCUSSION  
In clinical trials, multiple endpoints for treatment efficacy often are obtained (Pocock, Geller, 
and Tsiatis, 1987), and in addition, data may be collected hierarchically. Commonly used 
approaches, such as individual outcome data analysis, dimension reduction, or global test 
procedures, fail to borrow strength across outcomes, characterize relationships between 
outcomes or summarize those variables. Latent variable approaches provide a natural way to 
analyze complex multivariate hierarchical data, but seldom have been used to test hypotheses 
about clinical outcomes in clinical trial and other designed studies (Donaldson 2003). In 
addition, no existing commonly used software could analyze multivariate outcomes from 
hierarchical data with more than two levels. We have described a flexible Bayesian latent 
variable model for the situation where several binary outcomes are measured to assess an 
intervention effect in a cluster-randomized clinical trial with 3-level hierarchical data.  
Chapter 4 illustrates the single latent trait model in a cluster randomized clinical trial of 
three interventions to improve the processes of care for outpatients with pneumonia. Four binary 
outcomes are collected at the patient-level and clustered at the provider and clinic site levels.   
Simulation studies are conducted to check the algorithm and computational implementation. 
Chapter 5 extends the one latent trait model to a two-latent trait model using eight outcomes 
from both outpatient and inpatient care.  
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This latent modeling approach provides a comprehensive way to analyze multivariate 
hierarchical data.  The method not only allows assessment of intervention effects with respect to 
multiple outcomes by borrowing strength across outcomes, but also assesses the relationship 
between outcomes, identifies those outcomes that carry the most information about the latent 
trait(s), and provides a summary measure of the “quality of care” at each clinical site. Although 
the frequently used simple raw average methodology could also compute summary scores, it 
cannot be directly applied to clusters with missing data, or incorporate covariance information or 
relationships between latent variables, in contrast to model based approach (Skrondal and Rabe-
Hesketh, 2004).  
The proposed single latent trait model makes one important assumption, that a univariate 
latent variable explains the observed pattern in the data and that the intervention affects the 
outcomes in the similar way (same direction) , because we standardized by fixing the variance of 
the latent trait as 1 and truncating the factor loading {λh} below 0 for identification. This 
assumption is reasonable for the example of outpatient data used in Chapter 4 to illustrate the one 
latent trait model, because the individual outcome analyses show that the intervention has a 
positive effect on each outcome. Although oxygen assessment is poorly correlated with the other 
outcomes, indicating this outcome might measure a different underlying construct, removing it 
from the latent trait results in slightly bigger DIC, suggesting that the model with one trait 
constructed from the four outcomes fits better. In Chapter 5,  model identification is achieved by 
“anchoring” by fixing the scale of factor loading instead of ‘standardization’ and truncation, 
which relaxes the assumption of a common intervention effect, but loses the interpretation that 
higher latent scores indicate higher quality of pneumonia care when the estimates of factor 
loadings have different signs across outcomes. However, in order to model the covariance 
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structure between multiple latent traits, we used ‘anchoring” instead of “standardization”, 
because “standardization” constraint the variance of latent trait to be 1. In Chapter 5, we refit one 
latent trait model using outpatient data by “anchoring”, the results are consistent with the results 
in Chapter 4 using “standardization”. 
Due to the complexity of the model framework, in practice, latent variable models for 
hierarchical data could be framed in different ways for convenience.  We frame the one latent 
trait model in Chapter 4 by specifying the within-site and between-site models separately, to 
better interpret the within-in site and between-site variation for cluster-randomized hierarchical 
clinical data in the EDCAP study. The model could be extended by adding additional covariates 
to the within-site model, the between-site model and/or the model of latent variable level, as 
appropriate. In Chapter 5, we frame the model using the recent developed very general model 
framework of Generalized Linear Latent and Mixed Models ( GLLAMMs) (Skrondal & Rabe-
Hesketh, 2007; Skrondal & Rabe-Hesketh, 2004), by  writing two submodels: a response model 
and a structural model. The response model constructs latent variable(s) form the observed 
responses and the structural model regresses the latent variables as a function of intervention 
effect. Although the models were framed differently in Chapters 4 and 5, the underlying 
mathematical mechanisms are similar. 
Our models make one important assumption of conditional independence of outcomes 
given the latent traits, which plays a central role in latent variable models. In further work, we 
will consider extending the model to relax this local independence assumption to allow 
conditional dependence between outcomes. Although in our work, we considered the situation 
where the multiple outcomes are binary, different outcome types, including both continuous and 
discrete endpoints can be incorporated into the proposed model framework. Another extension of 
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this hierarchical model is to relax the assumption of homogeneity of variance, to examine 
whether interventions influence the degree of heterogeneity (variation) across health care 
providers. In this situation, estimates of variance components are of as great an interest as the 
regression coefficients. This joint modeling has been done for a single outcome (Hedeker, 
Mermelstein, and Demirtas, 2008), but not for multiple outcomes using a latent construct. 
Finally, our proposed two latent trait model models the outpatient and inpatient traits 
distinctly, which is reasonable for the EDCAP data because the two traits are poorly correlated 
conditional on the intervention effect. When the two traits are highly correlated, a possible 
extension would be to generate an overall trait constructed from those two individual latent traits, 
i.e., to estimate an overall intervention effect on this single latent trait or use this single trait to 
profile the health care providers.  
In summary, this latent modeling approach provides a comprehensive way to analyze 
multivariate hierarchical data.  The method not only allows assessment of intervention effects 
with respect to multiple outcomes, but also assesses the relationship between outcomes, 
identifies those outcomes that carry the most information about the latent trait(s), and provides a 
summary measure of the “quality of care” at each clinical site. Our work extends existing 
methods to model multivariate binary outcomes in a three-level hierarchical setting using one-
latent trait and two-latent trait models, and assesses the relationships between multiple latent 
traits. A practical application demonstrates potential usefulness of this approach to quantify 
intervention effects with regard to multiple endpoints in a cluster-randomized clinical trial.  
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APPENDIX A  
INDIVIDUAL OUTCOME DATA ANALYSIS 
To explore the data, random logistic regression models accounting for clustering effect at site level 
and provider level were fitted for each outcome separately, to estimate the intervention effect 
adjusting for patient risk levels.  
Both a Bayesian approach with WinBUGS and a maximum likelihood approach with the 
Stata Gllamm procedure were used to fit the models. Similar results were obtained based on the 
two different procedures. This demonstrates that the computation algorithm and the non-
informative prior specification in our Bayesian approach are reasonable. Posterior summaries and 
maximum likelihood estimators of the intervention effect were shown in table 6-1. In total, 24 
pairwise comparisons were conducted for the 8 outcomes. We noticed that the information derived 
from these individual outcome measures separately is overwhelming and not consistent across all 
outcomes. Furthermore, with this multidimensional outcome data, we expect some relationship 
among the outcomes, so that modeling outcomes independently would result in a loss of 
efficiency. 
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Table A-1 Bayesian and maximum likelihood estimations of intervention effects from individual 
outcome data analysis 
Outcomes comparisons Posterior summaries   Maximum likelihood 
method 
 Mean  Median sd 95% C.I. Est. S.E. 95% C.I. 
Outpatient processes 
Oxygen 
assessment  
Moderate vs. Low 0.11 0.12 0.70 (-1.27, 1.46) 0.10 0.61 (-1.09, 1.29) 
High vs. Low 0.42 0.43 0.74 (-1.05, 1.86) 0.40 0.63 (-0.82, 1.63) 
High vs. Moderate 0.31 0.32 0.62 (-0.95, 1.50) 0.30 0.53 (-0.73, 1.34) 
First dose of 
antibiotics in ED 
 
 
Moderate vs. Low 0.24 0.24 0.43 (-0.61, 1.08) 0.26 0.39 (-0.50, 1.01) 
High vs. Low 1.94 1.93 0.47 ( 1.01, 2.90) 1.90 0.42 (1.08, 2.72) 
High vs. Moderate 1.70 1.70 0.42 ( 0.88, 2.53) 1.65 0.37 (0.92, 2.37) 
Treatment with 
compliant 
antibiotic therapy 
in  ED 
Moderate vs. Low 0.18 0.15 0.49 (-0.71, 1.22) 0.19 0.43 (-0.66, 1.04) 
High vs. Low 1.78 1.76 0.47 ( 0.90, 2.73) 1.78 0.44 (0.93, 2.64) 
High vs. Moderate 1.60 1.60 0.41 ( 0.81, 2.39) 1.59 0.38 (0.86, 2.33) 
Compliant 
antibiotic therapy 
on discharge 
Moderate vs. Low 0.75 0.74 0.40 (-0.04, 1.56) 0.77 0.35 (0.08, 1.47) 
High vs. Low 0.97 0.96 0.42 ( 0.12, 1.84) 0.99 0.36 (0.28, 1.70) 
High vs. Moderate 0.22 0.23 0.36 (-0.46, 0.94) 0.22 0.32 (-0.41, 0.85) 
Inpatient processes 
Oxygen 
assessment 
Moderate vs. Low 1.56 1.50 0.99 (-0.22, 3.67) 1.34 0.71 (-0.04, 2.73) 
High vs. Low 0.22 0.20 0.86 (-1.43, 2.00) 0.21 0.61 (-0.97, 1.40) 
High vs. Moderate -1.34 -1.30 0.90 (-3.28, 0.37) -1.12 0.66 (-2.43, 0.17) 
Blood cultures 
before antibiotic 
administration 
Moderate vs. Low 0.12 0.12 0.31 (-0.48, 0.74) 0.18 0.27 (-0.36, 0.72) 
High vs. Low 0.91 0.91 0.31 ( 0.31, 1.52) 0.94 0.28 (0.40, 1.48) 
High vs. Moderate 0.79 0.79 0.28 ( 0.22, 1.36) 0.76 0.25 (0.27, 1.25) 
Antibiotic 
administration 
within 4  h 
Moderate vs. Low 0.08 0.08 0.33 (-0.57, 0.75) 0.11 0.29 (-0.47. 0.68) 
High vs. Low -0.13 -0.13 0.34 (-0.78, 0.55) -0.11 0.29 (-0.68, 0.46) 
High vs. Moderate -0.21 -0.21 0.29 (-0.79, 0.55) -0.22 0.26 (-0.73, 0.30) 
Treatment with 
compliant 
antibiotic therapy 
in ED 
Moderate vs. Low 0.67 0.66 0.35 ( 0.03, 1.37) 0.62 0.34 (-0.04, 1.29) 
High vs. Low 1.30 1.30 0.35 ( 0.64, 2.01) 1.27 0.34 (0.61, 1.93) 
High vs. Moderate 0.64 0.64 0.33 (-0.02, 1.28) 0.65 0.30 (0.05, 1.24) 
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APPENDIX B  
SELECTED WINBUGS FIGURES 
Gibbs sampling history plots (trace plot) and posterior density plots are given for three 
parameters of the intervention effect. We examined convergence of the two Monte Carlo Markov 
chains by checking the trace plot. In Chapter 4 of one latent trait model, each parameter of 
interest becomes stationary by 3,000 iterations, indicating that the convergence has been reached 
by 3,000 iterations. In Chapter 5 of two-latent trait model, we used the first 10000 iterations as 
burn in. The posterior density plots for parameters show unimodal distributions, which are nearly 
symmetric, and look close to normal.  
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Figure B-6-1 Gibbs sampling trace plots of outpatient intervention effect of moderate vs. low (r1), 
high vs. low (r1), and high vs. moderate ( r2- r1
  
) sequentially, one latent trait model in Chapter 4 
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Figure B-6-2 Posterior density plots for parameters of outpatient  intervention effect of moderate vs. 
low (r1), high vs. low (r1), and high vs. moderate ( r2- r1
 
) sequentially, one latent trait model in Chapter 4 
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Figure B-6-3 Gibbs sampling trace plots of outpatient and inpatient intervention effect of moderate 
vs. low (r1), high vs. low (r1), and high vs. moderate ( r2- r1
 
) sequentially, one latent trait model in Chapter 5 
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Figure B-6-4 Posterior density plots for parameters of outpatient and inpatient intervention effect of 
moderate vs. low (r1), high vs. low (r1), and high vs. moderate ( r2- r1
 
) sequentially, one latent trait model in 
Chapter 5 
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